* Aims to tackle disease include arthritis, diabetes, asthma
(Adds more on diseases, strategy, explanation of science)
Read more
Sunday, July 31, 2016
German stocks - Factors to watch on August 1
FRANKFURT, Aug 1 (Reuters) - The DAX top-30 index
looked set to open 1.1 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0638 GMT.
Read more
looked set to open 1.1 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0638 GMT.
Read more
BRIEF-BCWORLD PHARM to raise 2 bln won via private placement
* Says it will issue 62,304 shares of preferred stock
through private placement, with par value of 200 won per share,
for debt-equity swap
Read more
through private placement, with par value of 200 won per share,
for debt-equity swap
Read more
BRIEF-Luz Saude Q2 net profit down at 3.9 million euros
* Announced on Friday Q2 net profit of 3.9 million euros
($4.4 million), down 26.1 percent versus year ago
Read more
($4.4 million), down 26.1 percent versus year ago
Read more
BRIEF-Chengzhi revises to raise 12.5 bln yuan for 99.6 pct stake acquisition in Wison (Nanjing) Clean Energy
* Says it revises to issue up to 871.9 million shares at
14.32 yuan per share, to raise 12.5 billion yuan via private
placement for 99.6 percent stake acquisition in Wison (Nanjing)
Clean Energy
Read more
14.32 yuan per share, to raise 12.5 billion yuan via private
placement for 99.6 percent stake acquisition in Wison (Nanjing)
Clean Energy
Read more
BRIEF-Changzhou Qianhong Biopharma gets GMP certificate
* Says it received goods manufacture practice (GMP)
certificate from Jiangsu Food and Drug Administration Bureau,
for its bulk drug, Dalteparin Sodium
Read more
certificate from Jiangsu Food and Drug Administration Bureau,
for its bulk drug, Dalteparin Sodium
Read more
BRIEF-China Grand Automotive expects H1 net profit to rise 50-60 pct
* Says it expects H1 net profit to rise 50-60 percent y/y vs
net profit of 904 million yuan ($136.26 million) year ago
Read more
net profit of 904 million yuan ($136.26 million) year ago
Read more
UK urges pregnant women to reconsider travel to Zika-hit Florida
LONDON, July 30 (Reuters) - British health officials have
urged pregnant women to consider postponing non-essential travel
to Florida after the southern U.S. state confirmed the first
cases of the Zika virus that were not linked to travel.
Read more
urged pregnant women to consider postponing non-essential travel
to Florida after the southern U.S. state confirmed the first
cases of the Zika virus that were not linked to travel.
Read more
Saturday, July 30, 2016
BRIEF-Adma Biologics receives CRL from FDA for pending biologics license application
* CRL did not cite any concerns with clinical safety and
efficacy data for ri-002 submitted by adma in bla
Read more
efficacy data for ri-002 submitted by adma in bla
Read more
Friday, July 29, 2016
UPDATE 1-Bayer says will halt future U.S. sales of insecticide
CHICAGO, July 29 (Reuters) - The agricultural unit of German
chemicals company Bayer AG will halt future U.S.
sales of an insecticide that can be used on more than 200 crops
after losing a fight with the U.S. Environmental Protection
Agency, the company said on Friday.
Read more
chemicals company Bayer AG will halt future U.S.
sales of an insecticide that can be used on more than 200 crops
after losing a fight with the U.S. Environmental Protection
Agency, the company said on Friday.
Read more
BRIEF-Immune Pharmaceuticals offers up to 3.2 mln shares
* Says it is offering up to 3.2 million shares of co's
common stock to institutional investors - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
common stock to institutional investors - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
REFILE-Bayer to halt future U.S. sales of insecticide
CHICAGO, July 29 (Reuters) - The agricultural unit of German
chemicals company Bayer AG will halt future U.S.
sales of an insecticide used on more than 200 crops after losing
a fight with the U.S. Environmental Protection Agency, the
company said on Friday.
Read more
chemicals company Bayer AG will halt future U.S.
sales of an insecticide used on more than 200 crops after losing
a fight with the U.S. Environmental Protection Agency, the
company said on Friday.
Read more
BRIEF-Antibe Therapeutics reports 2016 year-end financial results
* Antibe Therapeutics reports 2016 year-end financial and
operating results
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
operating results
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Heron Therapeutics files for potential mixed shelf, size not disclosed - SEC Filing
* Files for potential mixed shelf, size not disclosed - SEC
Filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Trendy Miami neighborhood is first in U.S. with local Zika spread
MIAMI, July 29 (Reuters) - Christophe and Franziska Lefever
were admiring graffiti at an outdoor gallery in a chic Miami
arts district on Friday when they learned that the first cases
of Zika spread by mosquitos in the continental United States
were contracted in the area.
Read more
were admiring graffiti at an outdoor gallery in a chic Miami
arts district on Friday when they learned that the first cases
of Zika spread by mosquitos in the continental United States
were contracted in the area.
Read more
BRIEF-CDC director says widespread Zika transmission in U.S. unlikely
* CDC director Tom Frieden, in media conference call, says
first four suspected U.S. cases of locally transmitted Zika
virus, in Florida, not unexpected
Read more
first four suspected U.S. cases of locally transmitted Zika
virus, in Florida, not unexpected
Read more
BRIEF-Alkermes says U.S. District Court issued unambiguous opinion in favor of co, U.S. FDA - SEC filing
* On July 28 U.S. District Court for District of Columbia
issued unambiguous opinion in favor of co and U.S. FDA - SEC
filing
Read more
issued unambiguous opinion in favor of co and U.S. FDA - SEC
filing
Read more
UPDATE 1-Obama to showcase TPP after trade deal demonized in campaign
WASHINGTON, July 29 (Reuters) - During a visit from
Singapore's prime minister on Tuesday, President Barack Obama
will extol the Trans-Pacific Partnership (TPP) trade deal and
commit to getting the deal done, a top White House official said
on Friday, even though Obama's fellow Democrats panned it at
their convention this week.
Read more
Singapore's prime minister on Tuesday, President Barack Obama
will extol the Trans-Pacific Partnership (TPP) trade deal and
commit to getting the deal done, a top White House official said
on Friday, even though Obama's fellow Democrats panned it at
their convention this week.
Read more
BRIEF-Novo A/S reports 5 pct passive stake in Nabriva Therapeutics
* Novo A/S reports 5 pct passive stake in Nabriva
Therapeutics as of July 19, 2016 - SEC Filing
Source - http://bit.ly/2amiXtD
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
Therapeutics as of July 19, 2016 - SEC Filing
Source - http://bit.ly/2amiXtD
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
Fitch Upgrades Fresenius to 'BBB-'; Outlook Stable
(The following statement was released by the rating agency)
FRANKFURT/BARCELONA/LONDON, July 29 (Fitch) Fitch Ratings has
upgraded Fresenius
Medical Care AG & Co. KGaA's (FMC) and Fresenius SE & Co. KGaA's
(FSE; together
Fresenius) Long-Term Issuer Default Ratings to 'BBB-' from
'BB+'. The Outlooks
are Stable. Fitch has also upgraded the Short-Term IDR to 'F3'
from 'B'. A full
list of rating actions is below.
The upgrade reflects Fresenius' improving business risk profile,
driven by its
inc
Read more
FRANKFURT/BARCELONA/LONDON, July 29 (Fitch) Fitch Ratings has
upgraded Fresenius
Medical Care AG & Co. KGaA's (FMC) and Fresenius SE & Co. KGaA's
(FSE; together
Fresenius) Long-Term Issuer Default Ratings to 'BBB-' from
'BB+'. The Outlooks
are Stable. Fitch has also upgraded the Short-Term IDR to 'F3'
from 'B'. A full
list of rating actions is below.
The upgrade reflects Fresenius' improving business risk profile,
driven by its
inc
Read more
UPDATE 1-Florida reports evidence of local Zika transmission in U.S.
ORLANDO, Fla., July 29 (Reuters) - Florida's governor on
Friday reported the first evidence of local Zika virus
transmission in the continental United States, saying testing of
four residents showed they were likely infected by mosquito
bites.
Read more
Friday reported the first evidence of local Zika virus
transmission in the continental United States, saying testing of
four residents showed they were likely infected by mosquito
bites.
Read more
BRIEF-UK's CMA to review undertakings given BAE Systems 1999 deal
* To review undertakings given by British Aerospace Plc, now
BAE Systems Plc, arising from acquisition of General Electric Co
unit in Nov 1999
Read more
BAE Systems Plc, arising from acquisition of General Electric Co
unit in Nov 1999
Read more
UPDATE 1-Blockbuster drug Humira's sales drive AbbVie's profit
July 29 (Reuters) - AbbVie Inc posted
higher-than-expected quarterly profit and revenue, driven by
demand for flagship drug Humira, and raised its earnings
forecast for the year.
Read more
higher-than-expected quarterly profit and revenue, driven by
demand for flagship drug Humira, and raised its earnings
forecast for the year.
Read more
BRIEF-Glaxosmithkline Consumer Nigeria reports HY pre-tax profit of 424.8 mln naira
* HY ended June 30, 2016 group loss before tax of 3.62
billion naira versus profit of 424.8 million naira year ago
Read more
billion naira versus profit of 424.8 million naira year ago
Read more
BRIEF-Zhejiang Conba Pharma to invest further in online health service firm
* Says it plans to invest 146 million yuan ($21.96 million)
in online health service firm for another 8 percent stake,
bringing its holdings to 20 percent
Read more
in online health service firm for another 8 percent stake,
bringing its holdings to 20 percent
Read more
BRIEF-Enorama Pharma Q2 operating loss widens to SEK 3.5 million
* Q2 operating loss 3.5 million Swedish crowns
($405,000)versus loss 0.4 million crowns year ago
Source text: http://bit.ly/2aeEhzH
Read more
($405,000)versus loss 0.4 million crowns year ago
Source text: http://bit.ly/2aeEhzH
Read more
UPDATE 1-Insurer Cigna's profit misses estimates as medical costs rise
July 29 (Reuters) - Health insurer Cigna Corp
reported a lower-than-expected quarterly profit on Friday due to
a rise in medical costs in its business that sells plans under
the Affordable Care Act and a loss in its disability, life and
accident insurance division.
Read more
reported a lower-than-expected quarterly profit on Friday due to
a rise in medical costs in its business that sells plans under
the Affordable Care Act and a loss in its disability, life and
accident insurance division.
Read more
BRIEF-Beijing E-hualu expects to win elderly medical care project
* Says it expects to win elderly medical care project of
investment 707.9 million yuan ($106.38 million)
Read more
investment 707.9 million yuan ($106.38 million)
Read more
UPDATE 1-South African pharmaceutical workers launch pay strike
CAPE TOWN, July 29 (Reuters) - South African pharmaceutical
workers launched an indefinite wage strike on Friday,
potentially affecting production and distribution depots, a
union official said.
Read more
workers launched an indefinite wage strike on Friday,
potentially affecting production and distribution depots, a
union official said.
Read more
BRIEF-Core Logic to buy 98.96 pct stake in M.I.TECH for 30 bln won
* Says it will buy 98.96 percent stake (2.4 million shares)
in M.I.TECH CO.,LTD, from DONG-A ST CO.,LTD
Read more
in M.I.TECH CO.,LTD, from DONG-A ST CO.,LTD
Read more
BRIEF-Human Stem Cells Institute board approves additional share issue
* Says its board approves additional issue of 18 million ordinary shares in open
subscription
Source text: http://bit.ly/2aByzLw
Further company coverage:
(Gdynia Newsroom)
Read more
subscription
Source text: http://bit.ly/2aByzLw
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Biotest opens fifth plasma collection centre in Hungary
* Opens fifth plasma collection centre in Hungary
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Thursday, July 28, 2016
German stocks - Factors to watch on July 29
FRANKFURT, July 29 (Reuters) - The DAX top-30 index
looked set to open 0.6 percent higher on Friday, according to
premarket data from brokerage Lang & Schwarz at 0611 GMT.
Read more
looked set to open 0.6 percent higher on Friday, according to
premarket data from brokerage Lang & Schwarz at 0611 GMT.
Read more
BRIEF-Visiomed Group announces major distribution deal in US between BewellConnect and Henry Schein Medpod
* Distribution deal in US between BewellConnect and Henry
Schein Medpod
Source text: http://bit.ly/2aOAVTQ
Further company coverage:
(Gdynia Newsroom)
Read more
Schein Medpod
Source text: http://bit.ly/2aOAVTQ
Further company coverage:
(Gdynia Newsroom)
Read more
UPDATE 1-Safran H1 core income up 11.8 percent
PARIS, July 29 (Reuters) - France's Safran posted
an 11.8 percent rise in first-half core profit on Friday, driven
by demand for aircraft equipment like wheels and brakes, and
reaffirmed core financial targets.
Read more
an 11.8 percent rise in first-half core profit on Friday, driven
by demand for aircraft equipment like wheels and brakes, and
reaffirmed core financial targets.
Read more
French and Benelux stocks-Factors to watch on July 29
PARIS, July 29 (Reuters) - Below are company-related news
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
BRIEF-Kangmei Pharmaceutical signs cooperation agreement with China Unicom
* Says it signs strategic cooperation agreement with China
Unicom Guangdong branch, to cooperate on hospital information
system projects and other internet plus medical business
Read more
Unicom Guangdong branch, to cooperate on hospital information
system projects and other internet plus medical business
Read more
BRIEF-Senomyx enters letter agreement with Pepsico Inc to extend research period
* Entered letter agreement with pepsico, inc. To extend
research period under collaborative research and
development,license agreement dated aug 16, 2010
Read more
research period under collaborative research and
development,license agreement dated aug 16, 2010
Read more
UPDATE 1-FDA takes steps to protect blood supply in Florida amid Zika probe
CHICAGO, July 28 (Reuters) - The U.S. Food and Drug
Administration has ordered blood banks in Florida's two most
densely populated counties to stop collecting blood as health
officials determine whether Zika has begun transmission in the
continental United States.
Read more
Administration has ordered blood banks in Florida's two most
densely populated counties to stop collecting blood as health
officials determine whether Zika has begun transmission in the
continental United States.
Read more
BRIEF-Spring Bank Pharmaceuticals appoints Dr. Brady to board
* Spring bank pharmaceuticals appoints dr. Todd c. Brady to
its board of directors
Source text for Eikon:
Further company coverage:
Read more
its board of directors
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Becton Dickinson names Andrew Eckert to board of directors
* Names Andrew Eckert to board of directors
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Second Sight announces agreements to bring ARGUS II retinal prosthesis to Taiwan and Iran
* Second Sight announces two exclusive distribution
agreements to bring the ARGUS II retinal prosthesis to Taiwan
and Iran
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
agreements to bring the ARGUS II retinal prosthesis to Taiwan
and Iran
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Eli Lilly says authorities seek documents on PBM contracts
July 28 (Reuters) - Eli Lilly and Co said it
received a civil investigative demand from the U.S. attorney's
office for the southern district of New York, requesting
documents and information relating to contracts with pharmacy
benefit managers.
Read more
received a civil investigative demand from the U.S. attorney's
office for the southern district of New York, requesting
documents and information relating to contracts with pharmacy
benefit managers.
Read more
UPDATE 1-U.S. probes contracts between Eli Lilly and PBMs
July 28 (Reuters) - Eli Lilly and Co said it
received a civil investigative demand from the U.S. attorney's
office for the southern district of New York, requesting
documents and information relating to contracts with pharmacy
benefit managers (PBMs).
Read more
received a civil investigative demand from the U.S. attorney's
office for the southern district of New York, requesting
documents and information relating to contracts with pharmacy
benefit managers (PBMs).
Read more
BRIEF-Genticel says cash position at June 30 is EUR 14.7 million
* Cash & cash equivalents and liquid investments of 14.7
million euros ($16.28 million) as at June 30, 2016, in line with
company's expectations
Source text for Eikon:
Further company coverage:
($1 = 0.9027 euros)
(Gdynia Newsroom)
Read more
million euros ($16.28 million) as at June 30, 2016, in line with
company's expectations
Source text for Eikon:
Further company coverage:
($1 = 0.9027 euros)
(Gdynia Newsroom)
Read more
U.S. and UK form global partnership to speed new antibiotics
LONDON, July 28 (Reuters) - U.S. and British health
officials have created a new alliance with a budget of hundreds
of millions of dollars to accelerate the development of new
antibiotics and tackle the growing problem of drug resistance.
Read more
officials have created a new alliance with a budget of hundreds
of millions of dollars to accelerate the development of new
antibiotics and tackle the growing problem of drug resistance.
Read more
BRIEF-Germany's Merck KGaA, AmoyDx collaborate to bring liquid biopsy RAS biomarker testing to China
* Merck and Amoy Diagnostics Co Ltd collaborate to bring
liquid biopsy RAS biomarker testing to China
Read more
liquid biopsy RAS biomarker testing to China
Read more
Deals of the day- Mergers and acquisitions
July 28 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1430 GMT on
Thursday:
Read more
acquisitions and disposals were reported by 1430 GMT on
Thursday:
Read more
BRIEF-Pfizer and Western Oncolytics announce immuno-oncology research collaboration
* Pfizer and Western Oncolytics announce immuno-oncology
research collaboration to investigate novel oncolytic virus
technology
Read more
research collaboration to investigate novel oncolytic virus
technology
Read more
BRIEF-Hangzhou Tigermed Consulting to jointly set up equity investment partnership
* Says it will use 20 million yuan to jointly set up a
Shanghai-based equity investment partnership with an asset
management company via its related investment company
Read more
Shanghai-based equity investment partnership with an asset
management company via its related investment company
Read more
BRIEF-Argos Therapeutics says $50 mln share offering priced
* Argos Therapeutics announces pricing of $50 million public
offering of common stock and warrants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
offering of common stock and warrants
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Cowealth Medical Holding lowers conversion price of 1st series domestic unsecured convertible corporate bonds to T$87.55
* Says it lowers conversion price of 1st series domestic
unsecured convertible corporate bonds to T$87.55 from T$90.87,
effective Aug. 17
Read more
unsecured convertible corporate bonds to T$87.55 from T$90.87,
effective Aug. 17
Read more
BRIEF-CRH Medical Q2 revenue $16.59 mln versus $10.88 mln
* CRH Medical announces second quarter 2016 results
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
BRIEF-INC Research says Alistair Macdonald to succeed Jamie Macdonald as CEO
* Inc research announces transition of ceo role from jamie
macdonald to coo alistair macdonald effective oct. 1, 2016
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +1-646-223-8780)
Read more
macdonald to coo alistair macdonald effective oct. 1, 2016
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +1-646-223-8780)
Read more
New crop of robots to vie for space in the operating room
CHICAGO, July 28 (Reuters) - Even though many doctors see
need for improvement, surgical robots are poised for big gains
in operating rooms around the world.
Read more
need for improvement, surgical robots are poised for big gains
in operating rooms around the world.
Read more
UPDATE 1-Ipsen shares jump after raised guidance for specialty care
PARIS, July 28 (Reuters) - Shares of French drugmaker Ipsen
are up more than 6 percent on Thursday after the
company said it had raised its full-year guidance for specialty
care sales growth on the back of first half results.
Read more
are up more than 6 percent on Thursday after the
company said it had raised its full-year guidance for specialty
care sales growth on the back of first half results.
Read more
BRIEF-ED to buy stake in Beauty Island Group for 2.4 bln won
* Says it will buy 300,000 shares (30 percent stake) of
Beauty Island Group, for 2.4 billion won
Read more
Beauty Island Group, for 2.4 billion won
Read more
UPDATE 1-AstraZeneca earnings hit by waning cholesterol drug sales
* Drugmaker banking on cancer medicines for future growth
(Adds CEO comment and details on drugs)
Read more
(Adds CEO comment and details on drugs)
Read more
Wednesday, July 27, 2016
Swiss stocks - Factors to watch on July 28
ZURICH, July 28 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent firmer at 8227 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent firmer at 8227 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
MIDEAST STOCKS - Factors to watch - July 28
July 28 (Reuters) - Here are some factors that may affect
Middle East stock markets on Thursday. Reuters has not verified
the press reports and does not vouch for their accuracy.
Read more
Middle East stock markets on Thursday. Reuters has not verified
the press reports and does not vouch for their accuracy.
Read more
BRIEF-Fda approves Lixisenatide as Adlyxintm for treatment of adults with type 2 diabetes in U.S.
* Fda approves lixisenatide as adlyxintm for treatment of
adults with type 2 diabetes in u.s.
Read more
adults with type 2 diabetes in u.s.
Read more
BRIEF-Tactile Systems priced its IPO at $10.00 per share
* Priced its IPO of 4 million shares of common stock at a
public offering price of $10.00 per share.
Read more
public offering price of $10.00 per share.
Read more
BRIEF-Boryung Pharm to buy 32.7 pct stake in cell therapy product R&D firm for 1.5 bln won
* Says it will buy 32.7 percent stake (60,000 shares) in a
cell therapy product R&D firm, for 1.5 billion won
Read more
cell therapy product R&D firm, for 1.5 billion won
Read more
PRESS DIGEST- British Business - July 28
July 28 (Reuters) - The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
BRIEF-Brookdale Senior Living Inc enters into agreement to sell 44 communities
* Expect to use proceeds of transaction to primarily repay
debt in another step towards deleveraging balance sheet
Read more
debt in another step towards deleveraging balance sheet
Read more
BRIEF-Alere says is fully cooperating with U.S. DOJ investigation
* Received a U.S. Department Of Justice subpoena addressed
to alere toxicology services, inc. on July 1, 2016
Read more
to alere toxicology services, inc. on July 1, 2016
Read more
UK health service under fire over access to hepatitis C drugs
LONDON, July 28 (Reuters) - British health authorities
improperly restrict access to expensive new hepatitis C drugs
that can cure the liver-destroying disease, patient groups and a
leading medical journal charged on Thursday.
Read more
improperly restrict access to expensive new hepatitis C drugs
that can cure the liver-destroying disease, patient groups and a
leading medical journal charged on Thursday.
Read more
BRIEF-Uniqure presents updated clinical data in patients with severe Hemophilia B
* Uniqure presents updated clinical data in patients with
severe Hemophilia B demonstrating up to 9 months of sustained
levels of factor IX activity and therapeutic effect
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
severe Hemophilia B demonstrating up to 9 months of sustained
levels of factor IX activity and therapeutic effect
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-DBV Technologies Sa files for stock shelf with U.S. SEC size undisclosed - SEC Filing
* Says files for stock shelf with U.S. SEC; size undisclosed
- SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
- SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Conan Laughlin reports 9.9 pct passive stake in Almost Family
* North Tide Capital Master's Conan Laughlin reports 9.9 pct
passive stake in Almost Family Inc as of July 12 - SEC filing
Source text: (http://bit.ly/2arh1PN)
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
passive stake in Almost Family Inc as of July 12 - SEC filing
Source text: (http://bit.ly/2arh1PN)
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Quidel Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S
* Q2 earnings per share view $-0.24 -- Thomson Reuters
I/B/E/S
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
I/B/E/S
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Evoke Pharma Inc - SC13G
* Intracoastal Capital LLC reports 4.99 pct passive stake in
Evoke Pharma as of July 20- SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Evoke Pharma as of July 20- SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Sofinnova Venture Partners reports 6.6 pct passive stake in Audentes Therapeutics
* Sofinnova Venture Partners reports 6.6 pct passive stake
in Audentes Therapeutics as of July 20 - SEC filing
Source text: http://bit.ly/2aKKMdl
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
in Audentes Therapeutics as of July 20 - SEC filing
Source text: http://bit.ly/2aKKMdl
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
UPDATE 1-Teva purchase of Allergan generics business gets OK with conditions
WASHINGTON, July 27 (Reuters) - Teva Pharmaceutical
Industries Ltd won U.S. antitrust approval to purchase
Allergan Plc's generics business, after agreeing to
divest more than 75 generic drugs to rival firms, the Federal
Trade Commission said on Wednesday.
Read more
Industries Ltd won U.S. antitrust approval to purchase
Allergan Plc's generics business, after agreeing to
divest more than 75 generic drugs to rival firms, the Federal
Trade Commission said on Wednesday.
Read more
BRIEF-Txcell as of June 30 cash and cash equivalents amounted to EUR 3.2 million
* As of June 30, 2016, cash and cash equivalents amounted to
3.2 million euros ($3.52 million)
Source text for Eikon:
Further company coverage:
($1 = 0.9101 euros)
(Gdynia Newsroom)
Read more
3.2 million euros ($3.52 million)
Source text for Eikon:
Further company coverage:
($1 = 0.9101 euros)
(Gdynia Newsroom)
Read more
Scientists find potential new antibiotic, right under their noses
LONDON, July 27 (Reuters) - Scientists in Germany have
discovered a bacteria hiding out in peoples' noses that produces
an antibiotic compound that can kill several dangerous
pathogens, including the superbug MRSA.
Read more
discovered a bacteria hiding out in peoples' noses that produces
an antibiotic compound that can kill several dangerous
pathogens, including the superbug MRSA.
Read more
Three companies submit offers for Serbia's Galenika drug maker
BELGRADE, July 27 (Reuters) - An Indian company, a Brazilian
company and a British-Russian consortium have bid for a 25
percent stake in Serbia's Galenika pharmaceutical maker which
has debts of $220 million, the Economy Ministry said on
Wednesday.
Read more
company and a British-Russian consortium have bid for a 25
percent stake in Serbia's Galenika pharmaceutical maker which
has debts of $220 million, the Economy Ministry said on
Wednesday.
Read more
Ice Bucket Challenge credited with ALS breakthrough
July 27 (Reuters) - The Ice Bucket Challenge that went viral
two years ago, raising hundreds of millions of dollars, has
helped identify a new gene behind the neurodegenerative disease
ALS, or Lou Gehrig's disease, researchers say.
Read more
two years ago, raising hundreds of millions of dollars, has
helped identify a new gene behind the neurodegenerative disease
ALS, or Lou Gehrig's disease, researchers say.
Read more
BRIEF-Edwards Lifesciences gets pproval for Sapien 3 heart valve in Canada
* Edwards Lifesciences receives approval for sapien 3 heart
valve in canada
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
valve in canada
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
BRIEF-Oramed Pharmaceuticals says unit entered into general technical agreement with Premas Biotech
* Says unit Oramed Ltd. entered into a General Technical
Agreement with Premas Biotech Pvt. Ltd - SEC Filing
Read more
Agreement with Premas Biotech Pvt. Ltd - SEC Filing
Read more
IBM steps up efforts in fight against Zika
July 27 (Reuters) - International Business Machines Corp
said on Wednesday it would provide its technology and
resources to help track the spread of the Zika virus.
Read more
said on Wednesday it would provide its technology and
resources to help track the spread of the Zika virus.
Read more
BRIEF-Kadmon Holdings shares open at $11.55 in debut
* Kadmon Holdings LLC shares open at $11.55 in debut, below
IPO price of $12 per share
Further company coverage:
Read more
IPO price of $12 per share
Further company coverage:
Read more
BRIEF-Enwave extends license option agreement with Ultima Foods
* Enwave advances yogurt snack development with Ultima
Foods, extends technology evaluation and license option
agreement
Source text for Eikon:
Further company coverage:
Read more
Foods, extends technology evaluation and license option
agreement
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Stryker declares a $0.38 per share quarterly dividend
* Stryker declares a $0.38 per share quarterly dividend
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-RTI Surgical reports Q2 loss per share $0.05
* RTI surgical Inc says management and board of directors
are launching a comprehensive strategic review of company's
business lines
Read more
are launching a comprehensive strategic review of company's
business lines
Read more
BRIEF-Karyopharm says Selinexor received orphan drug designation from FDA
* Says Selinexor has received orphan drug designation from
U.S. Food and Drug Administration for treatment of soft tissue
sarcoma
Read more
U.S. Food and Drug Administration for treatment of soft tissue
sarcoma
Read more
BRIEF-Tactile Systems Technology sees IPO of 4.0 million shares
* Anticipate that the IPO price will be $10.00 per share
Source text - http://reut.rs/1oUTX8C
Further company coverage:
Read more
Source text - http://reut.rs/1oUTX8C
Further company coverage:
Read more
Lilly CEO Lechleiter to retire; Ricks to succeed
July 27 (Reuters) - Eli Lilly and Co said on
Wednesday Chief Executive John Lechleiter would retire by the
end of the year and would be succeeded by senior vice president
David Ricks on January 1.
Read more
Wednesday Chief Executive John Lechleiter would retire by the
end of the year and would be succeeded by senior vice president
David Ricks on January 1.
Read more
BRIEF-Pharma Mar reports H1 net loss of 13.2 million euros
* Said on Tuesday H1 sales are up 6.5 percent at 88.7
million euros ($97.6 million) versus year ago
Read more
million euros ($97.6 million) versus year ago
Read more
Deals of the day- Mergers and acquisitions
July 27 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1000 GMT on
Wednesday:
Read more
acquisitions and disposals were reported by 1000 GMT on
Wednesday:
Read more
BASF CEO says not parting with crop protection division
FRANKFURT, July 27 (Reuters) - BASF will not put
its Agricultural Solutions unit up for sale as part of an
ongoing consolidation wave in the crop protection and seeds
industry, the chemical group's chief executive said on
Wednesday.
Read more
its Agricultural Solutions unit up for sale as part of an
ongoing consolidation wave in the crop protection and seeds
industry, the chemical group's chief executive said on
Wednesday.
Read more
UPDATE 2-GlaxoSmithKline invests $360 mln in UK despite Brexit vote
* Investment at sites making respiratory and biotech drugs
(Adds government reaction, more on other post-Brexit
investments)
Read more
(Adds government reaction, more on other post-Brexit
investments)
Read more
BRIEF-Chem Tech Research to issue 5 bln won worth of convertible bonds
* Says it will issue the ninth unregistered/unsecured
private convertible bonds, raising 5 billion won in proceeds for
operations
Read more
private convertible bonds, raising 5 billion won in proceeds for
operations
Read more
BRIEF-Carl Zeiss Meditec names new chief for ophthalmology ops
* Carl Zeiss Meditec recruits James v. Mazzo to lead its
newly consolidated ophthalmology organization
Source text for Eikon:
Further company coverage:
Read more
newly consolidated ophthalmology organization
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Biotest opens new plasma collection centre in U.S.
* Opens new plasma collection centre in Clemson, South
Carolina, USA
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Carolina, USA
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Tuesday, July 26, 2016
BRIEF-Merck plans to end partnership agreement with Alk Abello
* Said on Tuesday MSD (known as Merck in the United States and Canada) had informed
ALK of its plans to end their partnership agreement
Read more
ALK of its plans to end their partnership agreement
Read more
Bayer's drugs unit secures Q2 earnings beat
FRANKFURT, July 27 (Reuters) - Bayer, the German
drugmaker trying to acquire U.S. seed company Monsanto,
easily surpassed second-quarter earnings expectations and raised
its full-year guidance on strong gains in stroke prevention pill
Xarelto and anti-blindness drug Eylea.
Read more
drugmaker trying to acquire U.S. seed company Monsanto,
easily surpassed second-quarter earnings expectations and raised
its full-year guidance on strong gains in stroke prevention pill
Xarelto and anti-blindness drug Eylea.
Read more
Knife attacker in Japan moved from jail to see prosecutors-NHK
TOKYO, July 27 (Reuters) - A Japanese man accused of
breaking into a facility for the disabled in a small town near
Tokyo before stabbing and killing 19 patients was taken from a
regional jail to see prosecutors on Wednesday, footage on public
broadcaster NHK showed.
Read more
breaking into a facility for the disabled in a small town near
Tokyo before stabbing and killing 19 patients was taken from a
regional jail to see prosecutors on Wednesday, footage on public
broadcaster NHK showed.
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 18-22
AirAsia X Bhd Q2 Aug 18-22
AMMB Holdings Bhd Q1 TBD
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiat
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 18-22
AirAsia X Bhd Q2 Aug 18-22
AMMB Holdings Bhd Q1 TBD
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiat
Read more
UPDATE 2-Third Point's 1st-half returns boosted by energy credit investments
NEW YORK, July 26 (Reuters) - Daniel Loeb's $16 billion
Third Point LLC said on Tuesday that the firm's investments in
energy credits drove positive returns during the first half of
the year and is devoting over $1 billion to energy corporate
credits.
Read more
Third Point LLC said on Tuesday that the firm's investments in
energy credits drove positive returns during the first half of
the year and is devoting over $1 billion to energy corporate
credits.
Read more
Third Point's 1st-half returns boosted by energy credit investments
NEW YORK, July 26 (Reuters) - Dan Loeb's Third Point LLC in
its second-quarter letter on Tuesday said the firm's investments
in energy credits drove positive returns during the first half
of the year.
Read more
its second-quarter letter on Tuesday said the firm's investments
in energy credits drove positive returns during the first half
of the year.
Read more
Honduras detects 8 cases of babies with Zika-related defect
TEGUCIGALPA, July 26 (Reuters) - Health officials in the
Central American nation of Honduras on Tuesday reported eight
cases of newborns with microcephaly born to women who were
infected with the Zika virus during pregnancy.
Read more
Central American nation of Honduras on Tuesday reported eight
cases of newborns with microcephaly born to women who were
infected with the Zika virus during pregnancy.
Read more
FDA enhances warnings on group of strong antibiotics
July 26 (Reuters) - The U.S. Food and Drug Administration
has enhanced warnings of side effects of a group of strong
antibiotics used to treat a variety of respiratory and urinary
tract infections and limited their use to patients with no
alternatives.
Read more
has enhanced warnings of side effects of a group of strong
antibiotics used to treat a variety of respiratory and urinary
tract infections and limited their use to patients with no
alternatives.
Read more
BRIEF-Merck sets quarterly dividend of $0.46 per share
* Sets quarterly dividend of $0.46 per share
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Genomic Vision H1 net loss widens to 4.0 million euros
* H1 net loss of 4.0 million euros versus loss of 2.2
million euros ($2.4 million) a year ago
Read more
million euros ($2.4 million) a year ago
Read more
BRIEF-Sangamo Biosciences says goal is to file investigational NDA for new factor VIII gene therapy
* Says goal is to file investigational New Drug Application
for New Factor VIII Gene Therapy approach in 2016
Read more
for New Factor VIII Gene Therapy approach in 2016
Read more
BRIEF-U.S. FDA updates warnings for Fluoroquinolone antibiotics
* Limiting Use Of Fluoroquinolone Antibiotics For Acute
Bacterial Sinusitis, Acute Bacterial Exacerbation Of Chronic
Bronchitis
Read more
Bacterial Sinusitis, Acute Bacterial Exacerbation Of Chronic
Bronchitis
Read more
Healthy clones: Dolly the sheep's heirs reach ripe old age
LONDON, July 26 (Reuters) - The heirs of Dolly the sheep are
enjoying a healthy old age, proving cloned animals can live
normal lives and offering reassurance to scientists hoping to
use cloned cells in medicine.
Read more
enjoying a healthy old age, proving cloned animals can live
normal lives and offering reassurance to scientists hoping to
use cloned cells in medicine.
Read more
Deals of the day- Mergers and acquisitions
July 26 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1330 GMT on Tuesday:
Read more
acquisitions and disposals were reported by 1330 GMT on Tuesday:
Read more
BRIEF-Starboard delivers letter to Depomed shareholders
* Given ownership stake, and special meeting would only
require one shareholder to consent, starboard to control timing
of special meeting
Read more
require one shareholder to consent, starboard to control timing
of special meeting
Read more
BRIEF-Fate Therapeutics receives patent for human induced pluripotent cells
* Fate Therapeutics announces issuance of U.S. Patent on
compositions of human induced pluripotent cells
Read more
compositions of human induced pluripotent cells
Read more
BRIEF-Mimedx reports Q2 adjusted earnings per share of $0.05
* Fy2016 earnings per share view $0.31, revenue view $243.9
million -- Thomson Reuters I/B/E/S
Read more
million -- Thomson Reuters I/B/E/S
Read more
BRIEF-Alimera Sciences sees Q2 revenue of $9.3 mln - $9.5 mln
* Says modified liquidity and revenue covenants in its
existing loan agreement with Hercules Capital Inc
Read more
existing loan agreement with Hercules Capital Inc
Read more
UPDATE 1-Health insurer Centene's profit beats; raises forecast
July 26 (Reuters) - Centene Corp reported a
better-than-expected quarterly profit as the health insurer
benefited from lower medical costs and an increase in Medicare
and commercial customers from its acquisition of rival Health
Net.
Read more
better-than-expected quarterly profit as the health insurer
benefited from lower medical costs and an increase in Medicare
and commercial customers from its acquisition of rival Health
Net.
Read more
BRIEF-CytoDyn first patient enrolled in late-stage HIV study
* First patient enrolled under newly modified protocol in
cytodyn's phase 3 pro 140 combination study in HIV
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +1-646-223-8780)
Read more
cytodyn's phase 3 pro 140 combination study in HIV
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +1-646-223-8780)
Read more
BRIEF-1nkemia gets financing of 200,000 euros for biofuel project
* Says gets approval for project aimed at preparation and
qualifying of new biofuels with financing for 1nkemia of 200,000
euros ($220,260)
Read more
qualifying of new biofuels with financing for 1nkemia of 200,000
euros ($220,260)
Read more
Newron stock jumps on hopes for Xadago drug
ZURICH, July 26 (Reuters) - * Shares in Newron
Pharmaceuticals rose around 15 percent on Tuesday on
hopes for its Parkinson's disease treatment Xadago
Read more
Pharmaceuticals rose around 15 percent on Tuesday on
hopes for its Parkinson's disease treatment Xadago
Read more
BRIEF-Immunicum will receive patent application in China on CD70
* Announced that a patent application in China regarding the
company's CD70-technology will be granted
Source text for Eikon:
Read more
company's CD70-technology will be granted
Source text for Eikon:
Read more
BRIEF-Double Bond Pharmaceutical: Orphan Drug Designation for Temodex
* Said on Monday it had been officially granted Orphan Drug Designation
(Orphan Drug) status for drug candidate Temodex by European Medicines Agency
(EMA)
Read more
(Orphan Drug) status for drug candidate Temodex by European Medicines Agency
(EMA)
Read more
BRIEF-Covestro aiming for at least 1.78 bln eur in FY EBITDA
* Aiming for at least 1.78 billion EUR in EBITDA for the
full year, up from an adjusted 1.64 billion in 2015
Read more
full year, up from an adjusted 1.64 billion in 2015
Read more
BRIEF-Cyberdyne to set up unit in US
* Says it plans to invest $100,000 to set up a wholly owned
subsidiary to control and promote the co's business in US, named
as Cyberdyne USA Inc in August
Read more
subsidiary to control and promote the co's business in US, named
as Cyberdyne USA Inc in August
Read more
Monday, July 25, 2016
Spanish stocks - Factors to watch on Tuesday
The following Spanish stocks may be affected by newspaper
reports and other factors on Tuesday. Reuters has not verified
the newspaper reports, and cannot vouch for their accuracy:
Read more
reports and other factors on Tuesday. Reuters has not verified
the newspaper reports, and cannot vouch for their accuracy:
Read more
Swiss stocks - Factors to watch on July 26
ZURICH, July 26 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.2 percent firmer at 8206 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.2 percent firmer at 8206 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
Singapore June factory output -0.3 pct y/y, bit weaker than expected
SINGAPORE, July 26 (Reuters) - Singapore's industrial
production in June fell slightly more than expected from a year
earlier, as sharp falls in marine and offshore engineering
output and pharmaceuticals production offset a jump in
electronics output.
Read more
production in June fell slightly more than expected from a year
earlier, as sharp falls in marine and offshore engineering
output and pharmaceuticals production offset a jump in
electronics output.
Read more
Japanese government spokesman told 19 dead after knife attack
TOKYO, July 26 (Reuters) - Japan's top government spokesman
said on Tuesday he had been told that 19 people were dead after
an attack by a knife-wielding man at a facility for the disabled
in central Japan.
Read more
said on Tuesday he had been told that 19 people were dead after
an attack by a knife-wielding man at a facility for the disabled
in central Japan.
Read more
BRIEF-Macrogen receives patent
* Says it receives a patent on July 25, for transformation
for production of lactate/lactic acid with high optical purity,
and preparing method of lactate/lactic acid using thereof
Read more
for production of lactate/lactic acid with high optical purity,
and preparing method of lactate/lactic acid using thereof
Read more
BRIEF-MB Financial to join S&P Midcap 400
* MB Financial to join S&P Midcap 400; Biotelemetry and
Raven Industries to join S&P Smallcap 600
Read more
Raven Industries to join S&P Smallcap 600
Read more
BRIEF-Mast Therapeutics expects to report top-line data in September
* Provided guidance on anticipated timing for announcement
of top-line data from epic study; expects to report top-line
data in September 2016
Read more
of top-line data from epic study; expects to report top-line
data in September 2016
Read more
BRIEF-Cryolife reports second quarter 2016 financial results
* FY2016 earnings per share view $0.21, revenue view $179.8
million -- Thomson Reuters I/B/E/S
Read more
million -- Thomson Reuters I/B/E/S
Read more
BRIEF-Acceleron Pharma appoints Thomas McCourt to its board
* Acceleron Pharma appoints Thomas McCourt to its board of
directors
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
directors
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-HCA Holdings names Heather Rohan president of tristar unit
* Heather Rohan to be appointed president of HCA's tristar
division
Source text for Eikon:
Further company coverage:
Read more
division
Source text for Eikon:
Further company coverage:
Read more
Zenefits fined $62,500 by Tenn. regulators in first settlement on licensing
SAN FRANCISCO, July 25 (Reuters) - Software startup Zenefits
must pay the state of Tennessee $62,500 for violating insurance
requirements, state officials said on Monday, marking the first
settlement with regulators as the scandal-hit company seeks to
redeem itself after revelations it had flouted the law.
Read more
must pay the state of Tennessee $62,500 for violating insurance
requirements, state officials said on Monday, marking the first
settlement with regulators as the scandal-hit company seeks to
redeem itself after revelations it had flouted the law.
Read more
Activist investor seeks Stada supervisory board overhaul
FRANKFURT, July 25 (Reuters) - An activist investor pushed
to tighten its grip over Stada on Monday by opposing
the appointment of four supervisory board members at the German
generic drugmaker, instead nominating four new non-executive
directors.
Read more
to tighten its grip over Stada on Monday by opposing
the appointment of four supervisory board members at the German
generic drugmaker, instead nominating four new non-executive
directors.
Read more
U.S. health officials update Zika transmission and testing guidance
July 25 (Reuters) - U.S. health officials issued updated
recommendations for preventing and testing for Zika infection on
Monday, warning that the virus can be transmitted through
unprotected sex with an infected female partner.
Read more
recommendations for preventing and testing for Zika infection on
Monday, warning that the virus can be transmitted through
unprotected sex with an infected female partner.
Read more
BRIEF-Torax Medical Inc says it has sold $25 million in equity financing
* Torax Medical Inc says it has sold $25 mln in equity
financing - SEC Filing
Source - http://bit.ly/2a9dbLl
(Bengaluru Newsroom; +1 646 223 8780)
Read more
financing - SEC Filing
Source - http://bit.ly/2a9dbLl
(Bengaluru Newsroom; +1 646 223 8780)
Read more
UPDATE 2-Colombia declares end to Zika epidemic inside country
BOGOTA, July 25 (Reuters) - The epidemic of the Zika virus
has officially ended in Colombia, the country's vice health
minister said on Monday, 10 months after the mosquito-borne
illness arrived in the Andean nation.
Read more
has officially ended in Colombia, the country's vice health
minister said on Monday, 10 months after the mosquito-borne
illness arrived in the Andean nation.
Read more
UPDATE 1-Spain registers first case in Europe of baby born with Zika-related defect
MADRID, July 25 (Reuters) - Spain has recorded the first
case in Europe of a baby born with the microcephaly birth defect
associated with the Zika virus, Spanish health authorities said
on Monday.
Read more
case in Europe of a baby born with the microcephaly birth defect
associated with the Zika virus, Spanish health authorities said
on Monday.
Read more
BRIEF-Deerfield Management Company, L.P reports 6.68 pct stake in Audentes Therapeutics
* Deerfield Management Company, L.P reports 6.68 pct stake
in Audentes Therapeutics as of July 25, 2016 - SEC Filing
Source - http://bit.ly/29VbnXH
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
in Audentes Therapeutics as of July 25, 2016 - SEC Filing
Source - http://bit.ly/29VbnXH
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
BRIEF-Allergan receives positive opinion for its treatment for IBS-D in adults
* Allergan receives positive opinion for Truberzi
(eluxadoline) for treatment of irritable bowel syndrome with
diarrhoea (IBS-D) in adults
Read more
(eluxadoline) for treatment of irritable bowel syndrome with
diarrhoea (IBS-D) in adults
Read more
BRIEF-Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
* On July 15, co entered into a settlement satisfaction
amendment with Livzon Mabpharm Inc - SEC filing
Read more
amendment with Livzon Mabpharm Inc - SEC filing
Read more
First baby with Zika-related microcephaly defect born in Spain
MADRID, July 25 (Reuters) - Spain has recorded its first
case of a baby born with the microcephaly birth defect
associated to the Zika virus, health authorities said on Monday.
Read more
case of a baby born with the microcephaly birth defect
associated to the Zika virus, health authorities said on Monday.
Read more
Germany plans to extend price brake for drugs under statutory insurance
BERLIN, July 25 (Reuters) - Germany wants to extend a price
brake for drugs covered by statutory health insurance for five
years beyond 2017, stretching out the measure introduced in
2009, a draft law seen by Reuters shows.
Read more
brake for drugs covered by statutory health insurance for five
years beyond 2017, stretching out the measure introduced in
2009, a draft law seen by Reuters shows.
Read more
BRIEF-Jaguar Animal Health reports positive data on Neonorm botanical extract
* Has entered into negotiations for potential exclusive
distribution relationship for pigs and dairy cattle in chinese
market
Read more
distribution relationship for pigs and dairy cattle in chinese
market
Read more
BRIEF-Syneron Medical Ltd says PicoWay Picosecond laser receives U.S. FDA clearance for ultra-short 785nm wavelength
* Syneron Candela's Picoway Picosecond laser receives U.S.
FDA clearance for ultra-short 785nm wavelength
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
FDA clearance for ultra-short 785nm wavelength
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine
* Merck is responsible for research, development,
manufacturing, and regulatory efforts in support of v920
Read more
manufacturing, and regulatory efforts in support of v920
Read more
UPDATE 1-FDA rejects Ocular's post-operative eye pain treatment
July 25 (Reuters) - Drug developer Ocular Therapeutix Inc
said the U.S. Food and Drug Administration had denied
approval for its treatment for post-operative eye pain.
Read more
said the U.S. Food and Drug Administration had denied
approval for its treatment for post-operative eye pain.
Read more
BRIEF-Apricus Biosciences expands existing partnership with Ferring Pharmaceuticals
* Apricus biosciences inc says apricus and sandoz agree to
mutually terminate license agreement
Read more
mutually terminate license agreement
Read more
CANADA STOCKS-Futures indicate slightly higher start to week
July 25 (Reuters) - Stock futures pointed to a slightly
higher opening for Canada's main stock index on Monday after G20
finance chiefs agreed over the weekend to use "all policy tools"
to lift global growth.
Read more
higher opening for Canada's main stock index on Monday after G20
finance chiefs agreed over the weekend to use "all policy tools"
to lift global growth.
Read more
PRESS DIGEST- Canada - July 25
July 25 (Reuters) - The following are the top stories from
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
BRIEF-My Size gets approval to list its stock on NASDAQ as'MYSZ'
* My size inc says received approval to list its common
stock on NASDAQ capital market under symbol 'MYSZ'
Read more
stock on NASDAQ capital market under symbol 'MYSZ'
Read more
Malaria drug may help in cancer fight, early research finds
LONDON, July 25 (Reuters) - An off-patent malaria drug could
help to destroy cancer cells by making them more susceptible to
radiotherapy, according to early work that has prompted British
scientists to start a clinical trial.
Read more
help to destroy cancer cells by making them more susceptible to
radiotherapy, according to early work that has prompted British
scientists to start a clinical trial.
Read more
Mozambique closes in on huge gas deal after years of delays
JOHANNESBURG, July 25 (Reuters) - Mozambique's long-delayed
offshore gas project with Italy's Eni could be approved
within months, sources close to the deal said, sparking
investments with the potential to transform one of the world's
poorest countries into a major energy player.
Read more
offshore gas project with Italy's Eni could be approved
within months, sources close to the deal said, sparking
investments with the potential to transform one of the world's
poorest countries into a major energy player.
Read more
BRIEF-Abbvie says CHMP grants positive opinion for shorter treatment duration with VIEKIRAX
* CHMP grants positive opinion for shorter treatment duration with Abbvie's VIEKIRAX
(ombitasvir/paritaprevir/ritonavir tablets) for patients with genotype 4 chronic hepatitis C
with compensated cirrhosis (child-pugh a)
Read more
(ombitasvir/paritaprevir/ritonavir tablets) for patients with genotype 4 chronic hepatitis C
with compensated cirrhosis (child-pugh a)
Read more
BRIEF-Neuron Bio obtains patent in Europe with possible use against Alzheimer's disease
* Says European Patents Office grants Neuron Bio with a
patent for a family of molecules derived from xantocillins with
potential use for neurodegenerative diseases including
Alzheimer's disease
Read more
patent for a family of molecules derived from xantocillins with
potential use for neurodegenerative diseases including
Alzheimer's disease
Read more
German stocks - Factors to watch on July 25
FRANKFURT, July 25 (Reuters) - The DAX top-30 index
looked set to open 0.1 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0641 GMT.
Read more
looked set to open 0.1 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0641 GMT.
Read more
Sunday, July 24, 2016
BRIEF-RaQualia Pharma says sodium channel blocker patent allowance in China
* Says the company received an allowance for a sodium
channel blocker substance patent in China (Application Number:
201180050306.2, Arylamide derivatives)
Read more
channel blocker substance patent in China (Application Number:
201180050306.2, Arylamide derivatives)
Read more
BRIEF-MDxHealth and Cerba Healthcare collaborate on SelectMDx commercialization
* MDxhealth and Cerba Healthcare announce collaboration
agreement for SelectMDx commercialization
Read more
agreement for SelectMDx commercialization
Read more
BRIEF-Sartorius lifts sales, EBITDA margin guidance
* Says group sales revenue for full year is now projected to
increase by about 15% to 18% in constant currencies
Read more
increase by about 15% to 18% in constant currencies
Read more
BRIEF-Nanjing Pharmaceutical issues 100 mln yuan debt financing instruments
* Says it completes 2016 first tranche private debt
financing instruments worth 100 million yuan
Read more
financing instruments worth 100 million yuan
Read more
Emerging market inflows boost demand for Indian dollar bonds
HONG KONG, July 25 (IFR) - Surging inflows into
emerging-market credit funds helped ONGC Videsh Vankorneft
nail tight pricing for a dual-tranche US dollar bond
last week, raising expectations for other Indian corporate
issuers waiting in the wings.
Read more
emerging-market credit funds helped ONGC Videsh Vankorneft
nail tight pricing for a dual-tranche US dollar bond
last week, raising expectations for other Indian corporate
issuers waiting in the wings.
Read more
BRIEF-Sichuan Kelun Pharmaceutical issues 1 bln yuan commercial paper
* Says it completed issuance of 1 billion yuan worth
commercial paper, with the term of 270 days
Read more
commercial paper, with the term of 270 days
Read more
'Brain training' cut dementia risk in healthy adults -U.S. study
CHICAGO, July 24 (Reuters) - A computerized brain training
program cut the risk of dementia among healthy people by 48
percent, U.S. researchers said on Sunday in reporting an
analysis of the results of a 10-year study.
Read more
program cut the risk of dementia among healthy people by 48
percent, U.S. researchers said on Sunday in reporting an
analysis of the results of a 10-year study.
Read more
Libyan health crisis sharpens as resources dwindle
TRIPOLI, July 24 (Reuters) - Unable to get specialist care
for his six-year-old daughter in Libya or a visa for treatment
abroad, Abdulhakim Shaybi bought a motor boat and set off with
her last month across the Mediterranean.
Read more
for his six-year-old daughter in Libya or a visa for treatment
abroad, Abdulhakim Shaybi bought a motor boat and set off with
her last month across the Mediterranean.
Read more
Olympics-The easiest thing to win at Rio Games? A ticket.
NEW YORK, July 24 (Reuters) - Over the past few weeks, one
U.S. marketing executive's phone has been ringing hot with
offers that many sports fans could only dream of: an
all-expenses-paid trip to watch the Olympic Games in Rio de
Janeiro next month.
Read more
U.S. marketing executive's phone has been ringing hot with
offers that many sports fans could only dream of: an
all-expenses-paid trip to watch the Olympic Games in Rio de
Janeiro next month.
Read more
China launches nationwide inspection of vaccines
SHANGHAI, July 23 (Reuters) - China health authorities have
started a nationwide inspection of vaccinations four months
after a scandal broke involving nearly $90 million worth of
illegal vaccines that were suspected of being sold in dozens of
provinces.
Read more
started a nationwide inspection of vaccinations four months
after a scandal broke involving nearly $90 million worth of
illegal vaccines that were suspected of being sold in dozens of
provinces.
Read more
Friday, July 22, 2016
DEALTALK-U.S. government's bid to block insurance mergers could spawn new ones
July 22 (Reuters) - The potential bust-up of two mega deals
among America's largest health insurance companies may have an
unintended result - more mergers.
Read more
among America's largest health insurance companies may have an
unintended result - more mergers.
Read more
BRIEF-Onconova adjusts pricing of rights offering
* Onconova adjusts pricing of rights offering
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Aurinia establishes at-the-market facility
* Says entered into a controlled equity offering sales
agreement with Cantor Fitzgerald & Co
Read more
agreement with Cantor Fitzgerald & Co
Read more
BRIEF-Steris acquired Medisafe Holdings for about £27 mln - SEC
* Effective July 22, co has acquired Medisafe Holdings Ltd
for approximately £27 million - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
for approximately £27 million - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-VBI Vaccines files for mixed shelf of upto $150 mln
* VBI Vaccines Inc files for mixed shelf of upto $150
million - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
million - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
U.S. RESEARCH ROUNDUP-D.R. Horton, Humana, Chicago Bridge & Iron
July 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Adeptus Health, Chipotle Mexican Grill and Yadkin
Financial, on Friday.
HIGHLIGHTS
* Chicago Bridge & Iron Co : Baird cuts to neutral
* D.R. Horton Inc : BofA Merrill cuts to neutral from buy
* Humana Inc : Wolfe Research raises to outperform
* Community Bank System Inc : Sandler O'Neill cuts to
Read more
on several U.S.-listed companies, including Adeptus Health, Chipotle Mexican Grill and Yadkin
Financial, on Friday.
HIGHLIGHTS
* Chicago Bridge & Iron Co : Baird cuts to neutral
* D.R. Horton Inc : BofA Merrill cuts to neutral from buy
* Humana Inc : Wolfe Research raises to outperform
* Community Bank System Inc : Sandler O'Neill cuts to
Read more
BRIEF-Bioanalytical Systems says John B. Landis retired as Chairperson
* Says John B. Landis retired as Chairperson of the board -
SEC Filing
Source - http://bit.ly/29U2Ks4
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
SEC Filing
Source - http://bit.ly/29U2Ks4
Further company coverage:
(Bengaluru Newsroom; +1 646 223 8780)
Read more
EU watchdog flags faulty generic drug data, backs sales halt
July 22 (Reuters) - The European Medicines Agency (EMA)
recommended suspending sales of some generic drugs after a
review found that data collected by a contract research company
in India for their approval was unreliable.
Read more
recommended suspending sales of some generic drugs after a
review found that data collected by a contract research company
in India for their approval was unreliable.
Read more
CORRECTED-FEATURE-Syrian refugees welcomed in recession-hit Brazil but face tough times
RIO DE JANEIRO, July 15 (Thomson Reuters Foundation) - When
Hanan Dacka fled the civil war in Syria with her family to start
a new life in Brazil, the idea that she might one day carry the
Olympic torch was beyond the stretch of anyone's imagination.
Read more
Hanan Dacka fled the civil war in Syria with her family to start
a new life in Brazil, the idea that she might one day carry the
Olympic torch was beyond the stretch of anyone's imagination.
Read more
UPDATE 1-U.S. charges three people in $1 bln Medicare fraud scheme
WASHINGTON, July 22 (Reuters) - The U.S. Department of
Justice unveiled its largest-ever criminal healthcare fraud case
against individuals on Friday, charging the owner of Miami-based
assisted living facilities and two others in a massive $1
billion Medicare fraud scheme.
Read more
Justice unveiled its largest-ever criminal healthcare fraud case
against individuals on Friday, charging the owner of Miami-based
assisted living facilities and two others in a massive $1
billion Medicare fraud scheme.
Read more
J&J unit Acclarent to pay $18 mln to settle false claims case
WASHINGTON, July 22 (Reuters) - Johnson & Johnson Inc
subsidiary Acclarent Inc., a California-based medical
device manufacturer, has agreed to pay $18 million to resolve
allegations that it caused healthcare providers to submit false
claims to Medicare and other federal healthcare programs, the
Justice Department said on Friday.
Read more
subsidiary Acclarent Inc., a California-based medical
device manufacturer, has agreed to pay $18 million to resolve
allegations that it caused healthcare providers to submit false
claims to Medicare and other federal healthcare programs, the
Justice Department said on Friday.
Read more
U.S. charges three people in $1 billion Medicare fraud scheme
WASHINGTON, July 22 (Reuters) - Three people have been
charged with conspiracy, obstructing justice, money laundering
and healthcare fraud in connection with a $1 billion scheme
involving Miami-based healthcare providers, the U.S. Justice
Department said on Friday.
Read more
charged with conspiracy, obstructing justice, money laundering
and healthcare fraud in connection with a $1 billion scheme
involving Miami-based healthcare providers, the U.S. Justice
Department said on Friday.
Read more
Investors scrap for Teva Pharmaceutical bonds
NEW YORK, July 22 (IFR) - Teva Pharmaceutical raised more
than US$20bn across three currencies this week via an
acquisition-driven bond that took advantage of pent-up demand
for corporate paper in a yield-starved market.
Read more
than US$20bn across three currencies this week via an
acquisition-driven bond that took advantage of pent-up demand
for corporate paper in a yield-starved market.
Read more
CANADA STOCKS-Futures indicate higher open after economic data
July 22 (Reuters) - Canada's main stock index futures
pointed to a higher start on Friday after retail sales data
exceeded estimates.
Read more
pointed to a higher start on Friday after retail sales data
exceeded estimates.
Read more
UPDATE 3-GE profit beats estimates as power revenue jumps
NEW YORK, July 22 (Reuters) - General Electric Co on
Friday reported a sharp rise in adjusted net income in the
second quarter, as its aviation, healthcare and power businesses
countered weak demand for oil and gas and transportation
equipment.
Read more
Friday reported a sharp rise in adjusted net income in the
second quarter, as its aviation, healthcare and power businesses
countered weak demand for oil and gas and transportation
equipment.
Read more
BRIEF-Heat Biologics suspends previously announced public offering
* Decided to suspend proposed public offering to explore
alternative options presented to company
Read more
alternative options presented to company
Read more
UPDATE 1-EU approves Monsanto, Bayer genetically modified soybeans
BRUSSELS, July 22 (Reuters) - The European Commission on
Friday approved imports of two types of Monsanto's
genetically modified soybeans and one sold by Germany's Bayer
CropScience for use as a food or animal feed.
Read more
Friday approved imports of two types of Monsanto's
genetically modified soybeans and one sold by Germany's Bayer
CropScience for use as a food or animal feed.
Read more
BRIEF-Conformis says Talbot Investments reported 7 pct passive stake in co as of May 31 - SEC filing
* Talbot Investments Ltd reports 7 pct passive stake in
Conformis as of May 31 - SEC filing
Source: (http://bit.ly/29YvLbF
)
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
Conformis as of May 31 - SEC filing
Source: (http://bit.ly/29YvLbF
)
Further company coverage:
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Amp Biosimilars FY 2015 net loss at 1.47 mln euros
* FY 2015 net loss 1.47 million euros (loss $1.62 million)
versus loss 90,200 euros year ago
Source text - http://bit.ly/29PVdPy
Further company coverage:
($1 = 0.9071 euros)
(Gdynia Newsroom)
Read more
versus loss 90,200 euros year ago
Source text - http://bit.ly/29PVdPy
Further company coverage:
($1 = 0.9071 euros)
(Gdynia Newsroom)
Read more
EU authorises Monsanto, Bayer genetically modified seeds
BRUSSELS, July 22 (Reuters) - The European Commission has
authorised two types of Monsanto's genetically modified
seeds and one sold by Germany's Bayer for feed and
food uses, following a favourable assessment by Europe's
scientific watchdog, it said on Friday.
Read more
authorised two types of Monsanto's genetically modified
seeds and one sold by Germany's Bayer for feed and
food uses, following a favourable assessment by Europe's
scientific watchdog, it said on Friday.
Read more
U.S. FDA raises concerns over Valeant's eye drop
July 22(Reuters) - Valeant Pharmaceuticals International
said on Friday U.S. regulators have raised
concerns over a new eye drop manufactured at a Bausch + Lomb
facility in Florida.
Read more
said on Friday U.S. regulators have raised
concerns over a new eye drop manufactured at a Bausch + Lomb
facility in Florida.
Read more
BRIEF-Airway Medix to issue D series shares to Adiuvio Investments
* Said on Thursday that it resolved to raise capital by 4
million zlotys ($1.0 million) via a share issue of 4 mln series
D shares
Read more
million zlotys ($1.0 million) via a share issue of 4 mln series
D shares
Read more
BRIEF-iNtRON Biotechnology completes private placement for 23.1 bln won
* Says it completes private placement of 420,000 shares of
common stock as of July 22, raising proceeds of 23.1 billion won
from the issue
Read more
common stock as of July 22, raising proceeds of 23.1 billion won
from the issue
Read more
BRIEF-TWi Pharmaceuticals says Allergan files patent infrigement litigation against it
* Says Allergan, Inc. filed a lawsuit against the company,
claiming its generic drug Restasis infriges Allergan's patent
Read more
claiming its generic drug Restasis infriges Allergan's patent
Read more
Thursday, July 21, 2016
UPDATE 1-Philips Lighting maintains outlook as core earnings rise
AMSTERDAM, July 22 (Reuters) - Philips Lighting,
the world's largest maker of bulbs and lighting systems, said on
Friday its core earnings rose 16 percent in the second quarter
and maintained its outlook for the full year.
Read more
the world's largest maker of bulbs and lighting systems, said on
Friday its core earnings rose 16 percent in the second quarter
and maintained its outlook for the full year.
Read more
Syngenta H1 profit squeezed by weak crop markets, Latam region
July 22 (Reuters) - Syngenta, the Swiss pesticides
and seeds maker being taken over by state-owned ChemChina,
reported a worse-than-expected drop in first-half profit, hurt
by weak agricultural markets and a continued decline of its
Latin American business.
Read more
and seeds maker being taken over by state-owned ChemChina,
reported a worse-than-expected drop in first-half profit, hurt
by weak agricultural markets and a continued decline of its
Latin American business.
Read more
BRIEF-BB Biotech Q2 net profit of CHF 36 mln
* Expects a return to growth from its portfolio holdings in
coming quarters and for FY 2016 as a whole
Read more
coming quarters and for FY 2016 as a whole
Read more
BRIEF-Hengkang Medical Group to form strategy cooperation framework with China International Economic Cooperation and Investment Inc
* Says it will enter into strategy cooperation framework
agreement with China International Economic Cooperation and
Investment Inc
Read more
agreement with China International Economic Cooperation and
Investment Inc
Read more
BRIEF-GuiZhou YiBai Pharmaceutical to pay 2015 div on July 28
* Says it will pay cash dividend of 0.2 yuan per 10 shares
(before tax) to shareholders for 2015 as a record of July 27
Read more
(before tax) to shareholders for 2015 as a record of July 27
Read more
BRIEF-SHINHUNG declares quarterly dividend as 100 won/share
* Says it will pay quarterly dividend as 100 won per share
on July 29, to shareholders recorded on June 30
Read more
on July 29, to shareholders recorded on June 30
Read more
Scientists hunt 'anti-evolution' drugs in new cancer fight
LONDON, July 22 (Reuters) - Scientists are opening a new
front in the war on cancer with plans to develop
"anti-evolution" drugs to stop tumour cells from developing
resistance to treatment.
Read more
front in the war on cancer with plans to develop
"anti-evolution" drugs to stop tumour cells from developing
resistance to treatment.
Read more
BRIEF-S&P says Aetna and Humana placed on creditwatch following U.S. DOJ announcement
* Intend to resolve the creditwatch placements after we
evaluate additional details surrounding the suit and assess
potential courses of action
Read more
evaluate additional details surrounding the suit and assess
potential courses of action
Read more
UPDATE 1-Doctors devise care plan for babies as Zika threat looms in U.S.
CHICAGO, July 21 (Reuters) - As U.S. public health officials try to determine whether Zika has arrived in the country, doctors are establishing guidelines on how to care for the rising number of babies whose mothers were infected with the virus during pregnancy.
Read more
Read more
BRIEF-Puma Biotech applies for marketing approval for breast cancer drug
* Submits NDA for PB272 (neratinib) to U.S. FDA for extended
adjuvant treatment of HER2-positive early stage breast cancer
Source text for Eikon:
Further company coverage:
Read more
adjuvant treatment of HER2-positive early stage breast cancer
Source text for Eikon:
Further company coverage:
Read more
Doctors devise care plan for babies as Zika threat looms in U.S.
CHICAGO, July 21 (Reuters) - As U.S. public health officials try to determine whether Zika has arrived in the country, doctors are establishing guidelines on how to care for the rising number of babies whose mothers were infected with the virus during pregnancy.
Read more
Read more
BRIEF-Abaxis Q1 earnings per share $0.30
* Board of directors has approved a $30 million increase to
its existing share repurchase program, to a total of $54 million
Read more
its existing share repurchase program, to a total of $54 million
Read more
BRIEF-Florida health officials rule out sex as well as travel in Miami-area woman's Zika infection- AP
* Florida health officials rule out sex as well as travel in
Miami area woman's Zika infection- AP
)
Read more
Miami area woman's Zika infection- AP
)
Read more
Fitch: Anthem & Aetna to Challenge DOJ Merger Block; Ratings Remain on Watch
(The following statement was released by the rating agency)
CHICAGO, July 21 (Fitch) Fitch Ratings said today that its
ratings on Anthem
Inc. (ANTM), Aetna Inc. (AET), Cigna Corp. (CI) and Humana Inc.
(HUM) remain on
Rating Watch following ANTM's and AET's separate announcements
that they intend
to challenge today's decisions by the Department of Justice's
(DOJ) to block
their respective acquisitions of CI and HUM.
Fitch anticipates the companies' ratings remaining on rating
watch pending t
Read more
CHICAGO, July 21 (Fitch) Fitch Ratings said today that its
ratings on Anthem
Inc. (ANTM), Aetna Inc. (AET), Cigna Corp. (CI) and Humana Inc.
(HUM) remain on
Rating Watch following ANTM's and AET's separate announcements
that they intend
to challenge today's decisions by the Department of Justice's
(DOJ) to block
their respective acquisitions of CI and HUM.
Fitch anticipates the companies' ratings remaining on rating
watch pending t
Read more
BRIEF-Advanced Inhalation Therapies files for withdraw U.S. IPO plans
* Requesting to withdraw ipo plans as it elected not to
pursue sale of securities at this time - sec filing
Read more
pursue sale of securities at this time - sec filing
Read more
BRIEF-Fujifilm to bid for Takeda's research reagents unit - Nikkei
* Fujifilm Holdings is set to make an offer for a laboratory
chemicals unit of Takeda Pharmaceutical - Nikkei
Read more
chemicals unit of Takeda Pharmaceutical - Nikkei
Read more
BRIEF-CDC says 400 pregnant women in U.S. with evidence of Zika infection
* U.S.. CDC says 400 pregnant women in u.s. With evidence of zika virus infection, up from 346 a week ago
Read more
Read more
BRIEF-Transgene to continue phase 1/1b study in chronic hepatitis B patients
* Transgene to continue phase 1/1b study with TG 1050 in
chronic hepatitis B patients on the recommendation of the
trial's safety review committee
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
chronic hepatitis B patients on the recommendation of the
trial's safety review committee
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Redhill Biopharma receives additional U.S. Patent covering RHB-105
* Redhill Biopharma receives additional U.S. patent covering
RHB-105 ahead of confirmatory phase III study for H. Pylori
infection
Read more
RHB-105 ahead of confirmatory phase III study for H. Pylori
infection
Read more
UPDATE 2-U.S. regulators sue to block Anthem-Cigna, Aetna-Humana insurer mergers
NEW YORK, July 21 (Reuters) - The U.S. Justice Department on
Thursday sued to challenge two separate health insurance
mergers, Anthem Inc's purchase of Cigna Corp and
Aetna Inc's acquisition of Humana Inc.
Read more
Thursday sued to challenge two separate health insurance
mergers, Anthem Inc's purchase of Cigna Corp and
Aetna Inc's acquisition of Humana Inc.
Read more
BRIEF-Biostage says cellspan implants being advanced, tested in preclinical studies
* Biostage appoints Harout Dersimonian, PH.D. as chief
scientific officer to oversee cell biology, materials science
and other research underlying its organ implant development
Read more
scientific officer to oversee cell biology, materials science
and other research underlying its organ implant development
Read more
U.S. regulators to block Anthem-Cigna, Aetna-Humana deals Thursday-source
NEW YORK, July 21 (Reuters) - U.S. antitrust regulators will
announce on Thursday plans to file lawsuits to block two
separate health insurance mergers, Anthem Inc.'s
purchase of Cigna Corp. and Aetna Inc.'s
acquisition of Humana Inc., according to a source
familiar with the matter.
Read more
announce on Thursday plans to file lawsuits to block two
separate health insurance mergers, Anthem Inc.'s
purchase of Cigna Corp. and Aetna Inc.'s
acquisition of Humana Inc., according to a source
familiar with the matter.
Read more
BRIEF-Relievant Medsystems receives FDA clearance for chronic low back pain drug, Intracept
* Relievant Medsystems Inc Receives FDA 510(k) clearance for
Intracept for the relief of chronic low back pain
Source text for Eikon:
Further company coverage: [Relievant Medsystems Inc]
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Intracept for the relief of chronic low back pain
Source text for Eikon:
Further company coverage: [Relievant Medsystems Inc]
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-CytoDyn submits orphan drug application to FDA for HIV drug
* CytoDyn submits orphan drug application to FDA for
pretreatment with PRO 140 of treatment-naïve HIV patients
Source text for Eikon:
Further company coverage:
Read more
pretreatment with PRO 140 of treatment-naïve HIV patients
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Roche CEO says very optimistic about u.s. market
* Ceo says still very optimistic about u.s. Market,
discussion about pricing was triggered by older generic drugs in
smaller markets
Source text for Eikon:
Further company coverage:
(Reporting By Zurich newsroom)
Read more
discussion about pricing was triggered by older generic drugs in
smaller markets
Source text for Eikon:
Further company coverage:
(Reporting By Zurich newsroom)
Read more
BRIEF-Roche CEO says Brexit impact is limited
* Roche ceo schwan says brexit impact is limited, uk
accounts for less than 3 percent of sales
Read more
accounts for less than 3 percent of sales
Read more
UPDATE 1-Galenica to buy biotech firm Relypsa for $1.5 bln before break-up
July 21 (Reuters) - Galenica has agreed to buy U.S.
biotech firm Relypsa for $1.53 billion in cash to
strengthen its Vifor Pharma unit ahead of splitting up the Swiss
healthcare group.
Read more
biotech firm Relypsa for $1.53 billion in cash to
strengthen its Vifor Pharma unit ahead of splitting up the Swiss
healthcare group.
Read more
Teva opens books on SFr1bn three-tranche bond
LONDON, July 21 (IFR) - Teva Pharmaceutical has started
marketing a SFr1bn three-tranche bond issue to help fund its
US$40.5bn acquisition of Actavis Generics, according to a lead
bank.
Read more
marketing a SFr1bn three-tranche bond issue to help fund its
US$40.5bn acquisition of Actavis Generics, according to a lead
bank.
Read more
BRIEF-AstraZeneca says antibiotic zavicefta met main goals in late-stage trial
* AstraZeneca's antibiotic zavicefta met primary endpoints
in phase III trial for treatment of hospital-acquired pneumonia
Source text for Eikon:
Further company coverage:
Read more
in phase III trial for treatment of hospital-acquired pneumonia
Source text for Eikon:
Further company coverage:
Read more
Wednesday, July 20, 2016
French and Benelux stocks-Factors to watch on July 21
PARIS, July 21 (Reuters) - Below are company-related news
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
and stories from French and Benelux media which could have an
impact on the region's markets or individual stocks.
Read more
Swiss stocks - Factors to watch on July 21
ZURICH, July 21 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Thursday.
Read more
main factors expected to affect Swiss stocks on Thursday.
Read more
German stocks - Factors to watch on July 21
FRANKFURT, July 21 (Reuters) - The following are some of the
factors that may move German stocks on Thursday:
Read more
factors that may move German stocks on Thursday:
Read more
BRIEF-KOLEN says conversion of convertible bonds worth 1 bln won
* Says 1 billion won worth of its seventh convertible bonds
have been converted into 307,503 shares of the company at 3,252
won per share
Read more
have been converted into 307,503 shares of the company at 3,252
won per share
Read more
BRIEF-BORYUNG PHARM announces patent granted
* Says it receives a patent, for pharmaceutical composition
of fimasartan and hydrochlorothiazide
Read more
of fimasartan and hydrochlorothiazide
Read more
BRIEF-Amgen announces settlement of securities litigation
* Settlement class consists of purchasers of Amgen's
publicly-traded securities during period from April 22, 2004,
through May 10, 2007
Read more
publicly-traded securities during period from April 22, 2004,
through May 10, 2007
Read more
BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab
* Chugai will continue to be responsible for product
manufacturing and supply of Nemolizumab.
Read more
manufacturing and supply of Nemolizumab.
Read more
BRIEF-Joint sees Q2 2016 revenue $4.8 million to $5.0 million
* For full year 2016, Joint Corp. Is reiterating guidance
for total revenues and adjusted EBITDA
Read more
for total revenues and adjusted EBITDA
Read more
UPDATE 1-J&J unit's former execs convicted of unapproved marketing
July 19 (Reuters) - Two former executives of Acclarent Inc,
a medical device company bought by Johnson & Johnson in
2010, were convicted on Wednesday by a U.S. jury on charges of
promoting a product for an unapproved use.
Read more
a medical device company bought by Johnson & Johnson in
2010, were convicted on Wednesday by a U.S. jury on charges of
promoting a product for an unapproved use.
Read more
BRIEF-Aegerion Pharmaceuticals unveils cost reduction plans
* Aegerion Pharmaceuticals says intends to withdraw
lomitapide from european union (eu) and certain other global
market
Source text for Eikon:
Further company coverage:
Read more
lomitapide from european union (eu) and certain other global
market
Source text for Eikon:
Further company coverage:
Read more
J&J unit's former execs convicted of unapproved marketing
July 19 (Reuters) - Two former executives of Acclarent Inc,
a medical device company bought by Johnson & Johnson in
2010, were convicted on Wednesday by a U.S. jury on charges of
promoting a product for an unapproved use.
Read more
a medical device company bought by Johnson & Johnson in
2010, were convicted on Wednesday by a U.S. jury on charges of
promoting a product for an unapproved use.
Read more
BRIEF-Teva announces pricing of EUR4.0 bln of senior notes
* Says tranches including eur1.75 billion of 0.375% fixed
rate senior notes maturing in 2020
Read more
rate senior notes maturing in 2020
Read more
French nursing home firm Korian posts 16 pct H1 revenue increase
July 20 (Reuters) - French nursing home operator Korian
reported a 16.3 percent increase in first half
revenues, boosted by recent foreign acquisitions.
Read more
reported a 16.3 percent increase in first half
revenues, boosted by recent foreign acquisitions.
Read more
BRIEF-Aetna ready to defend its deal if sued - CNBC
* Aetna Ready To Defend Its Deal If Sued, Has Divestitures
In Place - CNBC, citing source
Further company coverage: [AET.N HUM.N]
(Bengaluru Newsroom: +1 646 223 8780)
Read more
In Place - CNBC, citing source
Further company coverage: [AET.N HUM.N]
(Bengaluru Newsroom: +1 646 223 8780)
Read more
BRIEF-Amplitude Surgical FY sales of 80.7 million euros up 16.5%
* Financial Year 2015-16 sales of 80.7 million euros ($88.79
million), up 13.6 pct in actual terms and 16.5 pct at constant
currency
Read more
million), up 13.6 pct in actual terms and 16.5 pct at constant
currency
Read more
BRIEF-Mediclinic directors' pay report gets 85 pct votes at AGM
* 85.02 pct shareholders approve directors' remuneration
report for year
Source text for Eikon:
Further company coverage:
Read more
report for year
Source text for Eikon:
Further company coverage:
Read more
U.S. healthcare stock bulls look past political risks
NEW YORK, July 20 (Reuters) - With U.S. healthcare shares
looking cheap and business and demographic trends supporting the
industry's outlook, some investors are betting the sector will
resume beating the broader market it has out-gained for much of
the decade.
Read more
looking cheap and business and demographic trends supporting the
industry's outlook, some investors are betting the sector will
resume beating the broader market it has out-gained for much of
the decade.
Read more
BRIEF-Atrys Health to list on Spain's MAB at 1.48 euro per share
* Atrys Health to list at a reference price of 1.48 euro per
share and market capitalization of 16.5 million euros ($18.15
million)
Read more
share and market capitalization of 16.5 million euros ($18.15
million)
Read more
UPDATE 2-Unilever sharpens P&G rivalry by buying Dollar Shave Club
* Edgwell now a less attractive an M&A target for others
(Adds analyst comments, background, bullet points, byline)
Read more
(Adds analyst comments, background, bullet points, byline)
Read more
BRIEF-Apex therapeutics announces FDA acceptance of IND to evaluate tolerability, anti-tumor effects of APX3330
* Announces FDA acceptance of IND to evaluate the
tolerability and anti-tumor effects of APX3330
Source text for Eikon:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
tolerability and anti-tumor effects of APX3330
Source text for Eikon:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
BRIEF-Bioton changes Russian distributor
* Reported on Tuesday that it signed agreement on
terminating any previous contracts with BIOTEC OOO and its two
units, including contracts on production, exclusive
distribution, marketing and sale of company's product used in
treatment of diabetes on the territory of Russia
Read more
terminating any previous contracts with BIOTEC OOO and its two
units, including contracts on production, exclusive
distribution, marketing and sale of company's product used in
treatment of diabetes on the territory of Russia
Read more
BRIEF-Bellicum Pharmaceuticals says Baylor College receives Bellicum patent
* Says Baylor College of Medicine receives patent
exclusively licensed to Bellicum
Source text for Eikon:
Further company coverage:
Read more
exclusively licensed to Bellicum
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes
* Health Canada approves INVOKAMET for treatment of adults
with type 2 diabetes
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
with type 2 diabetes
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom : +1-646-223-8780)
Read more
African study exceeds U.N. 'test and treat' goal for ending HIV pandemic
NAIROBI, July 20 (Thomson Reuters Foundation) - A U.N. goal
to get seven out of 10 HIV positive people to take a test, start
medication and suppress the deadly virus in their blood is
achievable, a study in East Africa showed on Wednesday, raising
hopes of ending the AIDS pandemic.
Read more
to get seven out of 10 HIV positive people to take a test, start
medication and suppress the deadly virus in their blood is
achievable, a study in East Africa showed on Wednesday, raising
hopes of ending the AIDS pandemic.
Read more
Warburg Pincus to buy stake in Hygiena
July 20 (Reuters) - Warburg Pincus LLC has agreed to invest
in U.S. environmental testing and sanitation company Hygiena
LLC, the private equity firm said on Wednesday, gaining exposure
to a business that grew sharply over the past decade.
Read more
in U.S. environmental testing and sanitation company Hygiena
LLC, the private equity firm said on Wednesday, gaining exposure
to a business that grew sharply over the past decade.
Read more
BRIEF-Carl Zeiss Meditec says sales chief to leave the management board
* Says Thomas Simmerer will leave the management board
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Vietnam's Dhg Pharmaceutical says Q2 net profit down 1.3 pct y/y
* Vietnam's Dhg Pharmaceutical Co says Q2 net profit down
1.3 percent y/y at 147 billion dong ($6.6 million)
Further company coverage:
(Reporting By Mai Nguyen)
Read more
1.3 percent y/y at 147 billion dong ($6.6 million)
Further company coverage:
(Reporting By Mai Nguyen)
Read more
Teva marketing three-tranche euro-denominated M&A bond
LONDON, July 20 (IFR) - Teva Pharmaceutical has started
marketing an expected 4bn multi-tranche euro bond issue to help
fund its US$40.5bn acquisition of Actavis Generics, according to
a lead bank.
Read more
marketing an expected 4bn multi-tranche euro bond issue to help
fund its US$40.5bn acquisition of Actavis Generics, according to
a lead bank.
Read more
Indian shares rise as pharma stocks boost indexes
July 20 (Reuters) - Indian shares rose on Wednesday as drug
makers such as Glenmark Pharmaceuticals and Aurobindo
Pharma gained after getting approvals for generic
versions of a blockbuster cholesterol drug in the U.S.
Read more
makers such as Glenmark Pharmaceuticals and Aurobindo
Pharma gained after getting approvals for generic
versions of a blockbuster cholesterol drug in the U.S.
Read more
Tuesday, July 19, 2016
BRIEF-Collector Q2 profit after tax up at SEK 94 million
* Q2 total income 365 million Swedish crowns ($42.4 million) versus 296 million crowns year
ago
Read more
ago
Read more
BRIEF-PureTech's Akili adds two pharma venture funds to series B financing
* Puretech's Akili adds two pharma venture funds to series b
financing, increasing round to $42.4 million
Source text for Eikon:
Further company coverage:
Read more
financing, increasing round to $42.4 million
Source text for Eikon:
Further company coverage:
Read more
BRIEF- Cormorant Asset Management notifies 5.81 pct shareholding in Tigenix
* Tigenix: Cormorant Asset Management, LLC notifies 5.81 pct
shareholding in Tigenix
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
shareholding in Tigenix
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Aurora Optoelectronics unit to sell subscribed capital contribution in fund
* Says it Harbin-based unit to transfer 22 pct (worth of 110
million yuan) of subscribed capital contribution in an
investment fund to an individual, Zuo Hongbo
Read more
million yuan) of subscribed capital contribution in an
investment fund to an individual, Zuo Hongbo
Read more
BRIEF-Aurora Optoelectronics unit to invest 35.5 mln yuan to set up JV
* Says it Harbin-based unit to invest 35.5 million yuan to
set up joint venture in Dongguan, with Mr. Zhang Hong
Read more
set up joint venture in Dongguan, with Mr. Zhang Hong
Read more
BRIEF-Alteogen announces patent granted
* Says it receives a patent on July 4, for alpha-1
antitrypsin variant, preparation method thereof and use thereof
Read more
antitrypsin variant, preparation method thereof and use thereof
Read more
General Electric to partner with China's Huawei on 'industrial internet'
SHANGHAI, July 20 (Reuters) - General Electric Co on
Wednesday said it will partner with China's Huawei Technologies
Co Ltd to develop its "industrial internet" strategy.
Read more
Wednesday said it will partner with China's Huawei Technologies
Co Ltd to develop its "industrial internet" strategy.
Read more
BRIEF-KANGSTEM BIOTECH announces patent granted
* Says it receives a patent on July 18, for pharmaceutical
composition comprising stem cells treated with nod2 agonist or
culture thereof for prevention and treatment of immune disorders
and inflammatory diseases
Read more
composition comprising stem cells treated with nod2 agonist or
culture thereof for prevention and treatment of immune disorders
and inflammatory diseases
Read more
UPDATE 1-Florida health dept investigates possible local Zika transmission
July 19 (Reuters) - Florida health officials said on Tuesday they are investigating a case of Zika virus infection that does not appear to have stemmed from travel to another region with an outbreak.
Read more
Read more
PRESS DIGEST- Financial Times - July 20
July 20 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Judge refuses to block generic versions of AstraZeneca's Crestor
July 19 (Reuters) - A U.S. judge on Tuesday refused to issue
a temporary restraining order blocking the approval of new
generic versions of AstraZeneca's blockbuster
cholesterol drug Crestor in the United States.
Read more
a temporary restraining order blocking the approval of new
generic versions of AstraZeneca's blockbuster
cholesterol drug Crestor in the United States.
Read more
BRIEF-Auris Medical secures loan facility of up to $20 million
* Financing is in form of a 42-month loan bearing interest
at a minimum rate of 9.55% per annum
Read more
at a minimum rate of 9.55% per annum
Read more
BRIEF-U.S. CDC says one more outbreak of human salmonella infection was identified
* U.S. CDC investigation updates regarding eight multistate
outbreaks of human salmonella infections linked to live poultry
in backyard flocks
Read more
outbreaks of human salmonella infections linked to live poultry
in backyard flocks
Read more
Bayer says Monsanto offer not subject to any financing condition
BERLIN, July 19 (Reuters) - Bayer said its sweetened $64
billion acquisition offer for Monsanto would not be subject to
any financing conditions, responding to the U.S. seed company's
rejection of its latest proposal on Tuesday.
Read more
billion acquisition offer for Monsanto would not be subject to
any financing conditions, responding to the U.S. seed company's
rejection of its latest proposal on Tuesday.
Read more
UPDATE 4-Johnson & Johnson raises 2016 forecast, shares touch record high
July 19 (Reuters) - Johnson & Johnson on Tuesday
raised its full-year 2016 sales and earnings forecasts and
reported quarterly results that beat estimates, helped by
strength in its prescription drugs business.
Read more
raised its full-year 2016 sales and earnings forecasts and
reported quarterly results that beat estimates, helped by
strength in its prescription drugs business.
Read more
UPDATE 2-U.S. antitrust officials poised to block Anthem, Aetna deals - source
NEW YORK, July 19 (Reuters) - U.S. antitrust officials are
poised to file lawsuits to block Anthem Inc's
acquisition of Cigna Corp as well as Aetna Inc's
takeover of Humana Inc, a person familiar with the
matter told Reuters.
Read more
poised to file lawsuits to block Anthem Inc's
acquisition of Cigna Corp as well as Aetna Inc's
takeover of Humana Inc, a person familiar with the
matter told Reuters.
Read more
BRIEF-Justice Department to sue to block Anthem-Cigna and Aetna-Humana deals - source
* Justice Department to sue to block Anthem-Cigna and
Aetna-Humana deals, decision could be announced by end of next
week - source
(Reporting By Caroline Humer)
Read more
Aetna-Humana deals, decision could be announced by end of next
week - source
(Reporting By Caroline Humer)
Read more
Bosnia region to sell stake in drugmaker Bosnalijek on July 28
SARAJEVO, July 19 (Reuters) - Bosnia's autonomous
Bosniak-Croat Federation will sell 1.5 million shares in generic
drugmaker Bosnalijek on July 28, hoping to raise 23.4
million Bosnian marka ($13.3 million) and help plug a budget
gap.
Read more
Bosniak-Croat Federation will sell 1.5 million shares in generic
drugmaker Bosnalijek on July 28, hoping to raise 23.4
million Bosnian marka ($13.3 million) and help plug a budget
gap.
Read more
BRIEF-Arena Pharma, EISAI announce FDA approval of BELVIQ XR extended-release tablets
* Arena pharmaceuticals inc says in connection with
approval, arena will receive a $10 million milestone payment.
Read more
approval, arena will receive a $10 million milestone payment.
Read more
BRIEF-Agenus' chief financial officer, C.Evan Ballantyne to resign
* On july 14, 2016, C. Evan Ballantyne, chief financial
officer informed agenus of his intention to resign - sec filing
Read more
officer informed agenus of his intention to resign - sec filing
Read more
BRIEF-Ionis Pharmaceuticals licenses oral antisense drug to Janssen
* Ionis Pharmaceuticals licenses first oral antisense drug
acting locally in the GI tract to Janssen
Read more
acting locally in the GI tract to Janssen
Read more
BRIEF-Cerulean Pharma receives FDA fast track designation for ovarian cancer treatment
* Receives FDA fast track designation for CRLX101 for the
treatment of platinum-resistant ovarian cancer
Read more
treatment of platinum-resistant ovarian cancer
Read more
PRESS DIGEST- Canada - July 19
July 19 (Reuters) - The following are the top stories from
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
BRIEF-Dynamic Medical Technologies lowers conversion price of 2nd series domestic secured convertible corporate bonds to T$66.11
* Says it lowers conversion price of 2nd series domestic
secured convertible corporate bonds to T$66.11 from T$69.96,
effective Aug. 8
Read more
secured convertible corporate bonds to T$66.11 from T$69.96,
effective Aug. 8
Read more
BRIEF-Blirt two projects selected to be subsidised by PARP
* Said on Monday that two of its projects has been selected
for subsidising by the Polish Agency for Enterprise
Development(PARP)
Read more
for subsidising by the Polish Agency for Enterprise
Development(PARP)
Read more
BRIEF-Top choice Medical Investment unit establishes hospital jv
* Says its unit established a stomatological Hospital jv in
Yiyang with an individual on July 13
Read more
Yiyang with an individual on July 13
Read more
BRIEF-Evotec increases its profitability guidance for 2016
* Evotec says now expects adjusted group ebitda (before
changes in considerations) to more than double
Read more
changes in considerations) to more than double
Read more
Fitch Affirms Parkway Life REIT at 'BBB'; Outlook Stable
(The following statement was released by the rating agency)
SINGAPORE, July 19 (Fitch) Fitch Ratings has affirmed Parkway
Life Real Estate
Investment Trust's (PREIT) 'BBB' Long-Term Foreign-Currency
Issuer Default
Rating (IDR) and the 'BBB' rating on PREIT's SGD500m medium-term
note (MTN)
programme. The Outlook on the IDR is Stable.
KEY RATING DRIVERS
Strong Demand, Asset-Quality: PREIT's rating is driven by the
strong demand for
the services of its hospitals and elderly care homes, and
sup
Read more
SINGAPORE, July 19 (Fitch) Fitch Ratings has affirmed Parkway
Life Real Estate
Investment Trust's (PREIT) 'BBB' Long-Term Foreign-Currency
Issuer Default
Rating (IDR) and the 'BBB' rating on PREIT's SGD500m medium-term
note (MTN)
programme. The Outlook on the IDR is Stable.
KEY RATING DRIVERS
Strong Demand, Asset-Quality: PREIT's rating is driven by the
strong demand for
the services of its hospitals and elderly care homes, and
sup
Read more
BRIEF-WonIk to buy stake in WONIK HOLDINGS for 5.6 bln won
* Says it plans to acquire 14.5 million shares in WONIK
HOLDINGS CO.,LTD., a semiconductor co, for 5.6 billion won
Read more
HOLDINGS CO.,LTD., a semiconductor co, for 5.6 billion won
Read more
BRIEF-Amplifon buys two retail chains in Germany for a total of 86 shops
* Said on Monday it acquired retail chains Focus Hoeren AG
and Die Hoermeister GmbH in Germany operating a total of 86
shops
Read more
and Die Hoermeister GmbH in Germany operating a total of 86
shops
Read more
Monday, July 18, 2016
BRIEF-Neovacs and Stellar Biotechnologies launch Neostell, joint venture to manufacture Kinoids
* Neovacs and Stellar Biotechnologies announce launch of Neostell, joint venture to
manufacture Kinoids
Read more
manufacture Kinoids
Read more
German stocks - Factors to watch on July 19
FRANKFURT, July 19 (Reuters) - The following are some of the
factors that may move German stocks on Tuesday:
Read more
factors that may move German stocks on Tuesday:
Read more
Novartis says 2016 core operating profit may fall
ZURICH, July 19 (Reuters) - Novartis warned on
Tuesday that its core operating profit may decline this year as
it ramps up spending on marketing new heart failure drug
Entresto in the second half.
Read more
Tuesday that its core operating profit may decline this year as
it ramps up spending on marketing new heart failure drug
Entresto in the second half.
Read more
BRIEF-Nanjing Pharmaceutical to pay 2015 dividend on July 26
* Says it will pay cash dividend of 0.02 yuan per share
(before tax) for 2015 to shareholders of A shares of record on
July 25
Read more
(before tax) for 2015 to shareholders of A shares of record on
July 25
Read more
BRIEF-Jinyu Bio-Technology to invest 72.5 mln yuan to set up venture capital fund with partners
* Says it plans to invest 72.5 million yuan to establish a
venture capital fund with five partners including Inner Mongolia
Everbright Financial Holding Investment Management
Read more
venture capital fund with five partners including Inner Mongolia
Everbright Financial Holding Investment Management
Read more
BRIEF-Teva Pharmaceutical announces pricing of $15 bln of senior notes
* Announces pricing of $15 billion of senior notes in
connection with pending acquisition of Actavis Generics
Read more
connection with pending acquisition of Actavis Generics
Read more
BRIEF-B-Soft to buy 35 pct stake in environmental tech-co for 21 mln yuan
* Says it plans to acquire 35 percent stake in a
Zhejiang-based environmental technology firm
Read more
Zhejiang-based environmental technology firm
Read more
Surging heroin use threatens Kenya's HIV/AIDS gains
NAIROBI, July 19 (Thomson Reuters Foundation) - Rashid
Hassan Mohammed began using drugs when he was 15, after fleeing
an abusive home in the Kenyan coastal city of Mombasa and
joining a street gang that robbed and stole to buy heroin.
Read more
Hassan Mohammed began using drugs when he was 15, after fleeing
an abusive home in the Kenyan coastal city of Mombasa and
joining a street gang that robbed and stole to buy heroin.
Read more
Corvex builds small stakes in Monsanto, Bayer -sources
July 18 (Reuters) - Corvex Management LP, the activist fund
run by former Carl Icahn protégé Keith Meister, has amassed
small stakes in U.S. seeds company Monsanto Co and its
aspiring acquirer, Germany's Bayer AG, people
familiar with the matter said on Monday.
Read more
run by former Carl Icahn protégé Keith Meister, has amassed
small stakes in U.S. seeds company Monsanto Co and its
aspiring acquirer, Germany's Bayer AG, people
familiar with the matter said on Monday.
Read more
UPDATE 2-Dozens of wrestlers sue WWE over neurological injuries
July 18 (Reuters) - World Wrestling Entertainment Inc was sued on Monday by Jimmy "Superfly" Snuka and dozens of other retired male and female wrestlers seeking to hold it responsible for neurological injuries they claimed to suffer by participating in its bouts.
Read more
Read more
Republican 2016 platform calls for reinstating 1933 banking law
July 18 (Reuters) - The U.S. Republican Party's newly
adopted policy platform calls for reinstating the 1933
Glass-Steagall law requiring the separation of commercial and
investment banking, according to language released on Monday.
Read more
adopted policy platform calls for reinstating the 1933
Glass-Steagall law requiring the separation of commercial and
investment banking, according to language released on Monday.
Read more
UPDATE 1-SoftBank's ARM buy may net bankers $120 million in fees
LONDON/NEW YORK, July 18 (Reuters) - Bankers are set to
share up to $120 million in fees thanks to SoftBank Group Corp's
planned $32 billion acquisition of British chip
designer ARM Holdings, according to estimates on Monday.
Read more
share up to $120 million in fees thanks to SoftBank Group Corp's
planned $32 billion acquisition of British chip
designer ARM Holdings, according to estimates on Monday.
Read more
BRIEF-Cynapsus provides European clinical update for parkinson's drug
* APL-130277 for the treatment of off episodes in patients
with Parkinson's disease
Source text for Eikon:
Further company coverage:
Read more
with Parkinson's disease
Source text for Eikon:
Further company coverage:
Read more
BRIEF-James Tananbaum reports 5.9 pct passive stake in Nanostring Tech
* James Tananbaum reports 5.9 percent passive stake in
Nanostring Technologies Inc as of July 7
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Nanostring Technologies Inc as of July 7
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
BRIEF-Cynapsus announces positive phase 3 results for Parkinson's drug
* New drug application for CTH-300 and CTH-301 with FDA
expected to be submitted in first half of 2017.
Read more
expected to be submitted in first half of 2017.
Read more
UPDATE 1-German and French firms take biggest share of ECB credit splurge
FRANKFURT, July 18 (Reuters) - The European Central Bank
snapped up debt of blue-chip names such as BMW, Sanofi
and BASF as Germany and France accounted
for the lion's share of its first batch of corporate bond
purchases.
Read more
snapped up debt of blue-chip names such as BMW, Sanofi
and BASF as Germany and France accounted
for the lion's share of its first batch of corporate bond
purchases.
Read more
BRIEF-ANI Pharmaceuticals announces FDA approval, launch of Nilutamide tablets
* ANI Pharmaceuticals announces FDA approval and immediate
launch of Nilutamide tablets, the first generic competitor to
Nilandron
Read more
launch of Nilutamide tablets, the first generic competitor to
Nilandron
Read more
BRIEF-Syneron Candela says announces FDA clearance of its non-invasive fat destruction device
* Syneron candela announces fda clearance of high energy
ultrashape power for fat destruction
Read more
ultrashape power for fat destruction
Read more
BRIEF-EMC Instytut Medyczny negotiates acquisition of ACZ units
* Agrees terms of potential acquisition of 100 percent
stakes in companies operating under Aktywne Centrum Zdrowia
(ACZ) brand: NZOZ Zawidawie sp. z o.o., Q-Med sp. z o.o. and CM
Medyk sp. z o.o.
Read more
stakes in companies operating under Aktywne Centrum Zdrowia
(ACZ) brand: NZOZ Zawidawie sp. z o.o., Q-Med sp. z o.o. and CM
Medyk sp. z o.o.
Read more
BRIEF-Asterias Biotherapeutics appoints Ryan Chavez as general counsel
* Asterias Biotherapeutics appoints Ryan Chavez as EVP of
Finance and general counsel
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Finance and general counsel
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
Deals of the day- Mergers and acquisitions
July 18 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 10:00 GMT on Monday:
Read more
acquisitions and disposals were reported by 10:00 GMT on Monday:
Read more
BRIEF-Shanghai Conant Optics expects H1 2016 net profit to increase by 9.43 to 38.61 pct
* Says net profit for H1 of 2016 expected to increase by
9.43 percent to 38.61 percent, or to be 22.5 million to 28.5
million yuan
Read more
9.43 percent to 38.61 percent, or to be 22.5 million to 28.5
million yuan
Read more
BRIEF-Biogen SB5 accepted for review by European Medicines Agency
* Sb5, an adalimumab biosimilar referencing humira,
accepted for review by european medicines agency
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
accepted for review by european medicines agency
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
BRIEF-Nantong Jinghua Pharmaceutical cuts share issue size to 554.9 mln yuan to 800 mln yuan
* Says it will raise up to 554.9 million yuan in private
placement of shares to fund acquisition, projects, instead of
800 million yuan, which was disclosed on July 1
Read more
placement of shares to fund acquisition, projects, instead of
800 million yuan, which was disclosed on July 1
Read more
Airbus says Turkey's Pegasus Airlines will take new A320 jet
LONDON, July 18 (Reuters) - Turkey's Pegasus Airlines will
take delivery of its first A320neo jetliner as planned this
week, Airbus said, reversing earlier indications that the
delivery would be postponed following Friday's thwarted coup
attempt in the country.
Read more
take delivery of its first A320neo jetliner as planned this
week, Airbus said, reversing earlier indications that the
delivery would be postponed following Friday's thwarted coup
attempt in the country.
Read more
BRIEF-Chongqing Lummy Pharmaceutical sees 2016 H1 net profit up 180.1 pct to 207.2 pct
* Sees net profit for 2016 H1 up 180.1 percent to 207.2
percent, or to be 31 million yuan to 34 million yuan
Read more
percent, or to be 31 million yuan to 34 million yuan
Read more
BRIEF-Astrazeneca's lung cancer drug meets primary endpoint in late-stage trial
* Objective response rate, disease control rate, duration of
response achieved clinically meaningful improvement versus
chemotherapy
Read more
response achieved clinically meaningful improvement versus
chemotherapy
Read more
UPDATE 1-UK Stocks-Factors to watch on July 18
July 18 (Reuters) - Britain's FTSE 100 index is seen opening up 16
points, or 0.2 percent, on Monday according to financial bookmakers, with
futures up 0.4 percent ahead of the cash market open. For more on the
factors affecting European stocks, please click on
Read more
points, or 0.2 percent, on Monday according to financial bookmakers, with
futures up 0.4 percent ahead of the cash market open. For more on the
factors affecting European stocks, please click on
Read more
Sunday, July 17, 2016
German stocks - Factors to watch on July 18
FRANKFURT, July 18 (Reuters) - The DAX top-30 index
looked set to open 0.2 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0612 GMT.
Read more
looked set to open 0.2 percent higher on Monday, according to
premarket data from brokerage Lang & Schwarz at 0612 GMT.
Read more
Swiss stocks - Factors to watch on July 18
ZURICH, July 18(Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent lower at 8,150 points on Monday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent lower at 8,150 points on Monday,
according to premarket indications by bank Julius Baer
.
Read more
Roche says Gazyva does not meet primary endpoint in phase III testing
ZURICH, July 18 (Reuters) - Roche's Gazyva did not
significantly reduce the risk of disease worsening or death
compared to an alternative treatment for people with previously
untreated diffuse large B-cell lymphoma in a phase III GOYA
test, the company said on Monday.
Read more
significantly reduce the risk of disease worsening or death
compared to an alternative treatment for people with previously
untreated diffuse large B-cell lymphoma in a phase III GOYA
test, the company said on Monday.
Read more
BRIEF-Jiangxi Fushine Pharmaceutical expects H1 2016 net profit to increase by 100 to 130 pct
* Says net profit for H1 of 2016 expected to increase by 100
percent to 130 percent, or to be 81.5 million to 93.8 million
yuan
Read more
percent to 130 percent, or to be 81.5 million to 93.8 million
yuan
Read more
BRIEF-Sinocare sees 2016 H1 net profit to decrease by 10~40 pct
* Sees 2016 H1 net profit to decrease by 10~40 percent, or
to be 45,028,200 yuan to 67,542,400 yuan, compared to net profit
of H1 of 2015(75,047,100 yuan)
Read more
to be 45,028,200 yuan to 67,542,400 yuan, compared to net profit
of H1 of 2015(75,047,100 yuan)
Read more
BRIEF-Cowealth Medical Holding to issue 2nd series domestic unsecured convertible corporate bonds of T$600 mln
* Says it will issue 2nd series domestic unsecured
convertible corporate bonds of T$600 million
Read more
convertible corporate bonds of T$600 million
Read more
Subscribe to:
Posts (Atom)